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ABSTRACT 
 
Introduction 
Limited research has been conducted on the causes and economic impacts of expired 
medicine, yet medicine costs comprise a significant proportion of healthcare 
expenditure. Medicines and their management are an important health system 
function, necessary for improving and maintaining health. However the lack and 
wastage of essential medicine is still one of the most serious public health problems 
globally, including South Africa. The high rate of medicine expiry highlights a problem 
throughout the supply chain and this wastage reduces the quantity of medicines 
available to patients and therefore the quality of healthcare they receive. This study 
aimed to estimate the revenue loss due to expired medicines within a hospital setting 
from January 2011 to June 2014 and explore reasons for this. 
Methods 
This mixed methods study is a retrospective analysis review of forty-two months of 
expired medicine reports extracted at a public sector hospital coupled with a qualitative 
exploration (through semi-structured in-depth interviews) with key stakeholders about 
possible reasons for the expiration of medicines. In addition, informal observations 
were conducted across the duration of the fieldwork and recorded in a researcher 
diary. Ethics and research approvals for the study were obtained from the University 
of Witwatersrand Human Ethics Committee and the hospital.  
Results 
32,368 medicines had expired over the study period. These data were drawn from the 
wards, outpatient departments and pharmacy and consisted of 68 different Anatomical 
Therapeutic Chemical (ATC) classes. More than 80% of the expired medicines were 
on the essential medicine list (EML) with antibacterial for systemic use (16%, n=5067) 
and antivirals for systemic use (15%, n=4970) among the highest classes that expired. 
The estimated total value of expired medicine for the study period was R838 029; an 
estimated annual revenue loss of 0.6% of the hospital’s total pharmaceutical 
expenditure; and an average increase in percentage revenue loss of 72% for the study 
period. Two main themes emerged from the in-depth interviews conducted with key 
stakeholders; i) Knowledge, understanding and practical application of policies and 
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procedures related to expired medicines, and ii) Diversion from Ideal: procedures and 
constraints which may impact implementation. A closer examination to explore the 
reasons for these diversions - the ‘whys’- revealed three thematic areas: mistrust 
among employees and in the system, fear of being ‘caught’ yet lack of accountability 
and, ineffective communication and coordination. 
 
Discussion 
Expiry of medicines was highest among essential medicine on the supply-side. 
Medicines management is not restricted to pharmacists and although adequate tools 
for quantification and demand planning exist, none of these are focused on the health 
worker who has no formal training in medicine supply management. The study 
highlighted the need to identify effective strategies for phasing in and out of 
pharmaceutical policies and tenders to minimize waste. There is a lack of standard 
treatment guideline knowledge among prescribers. The extent of expired medicines at 
patients’ homes, patient returns or cost of disposing off expired medicine were not 
analysed. The relationship between governing documents and daily practices are not 
well understood by those responsible for managing medicines and accountability is 
not clearly assigned. 
 
Recommendations and Conclusion 
Creating awareness about the risk of medicines expiring and cost impact on service 
delivery should be communicated to healthcare workers and policy makers. Medicine 
supply management should be included as part of job descriptions of employees who 
manage medicines at this hospital to enhance accountability. Employing clinical 
pharmacists in the wards at tertiary hospitals may improve medicine management. 
Continuous monitoring and periodic evaluations to identify and address challenges 
related to medicine wastage is paramount to reduce financial loss and improve health 
outcomes. Sound coordination and communication is needed between the pharmacy 
and other departments in the hospital. Additionally, Pharmaceutical and Therapeutics 
Committees should emphasise the use of Standard Treatment Guidelines. 
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CHAPTER 1: INTRODUCTION AND BACKGROUND 
__________________________________________________________________________________ 
1.1 Introduction 
 
Although medicines comprise a significant proportion of healthcare expenditure, 
limited research on the causality and economic impact of expired medicines exists 
(Barraclough and Clark, 2011). Some of the leading causes of expiry of medicines 
include poor pharmaceutical management, lack of human resources and lack of 
accountability (World Health Organisation, 1998). Expiry of medicines leads to 
significant wastage of resources which may result in reduced availability of medicines. 
This may impact on the quality of healthcare provided to patients and ultimately the 
loss of confidence in the health system (Nakyanzi et al., 2010). This may also affect 
the affordability of healthcare for patients by increasing transport costs and out of 
pocket payments. 
In 2010, the World Health Organization (WHO) estimated that approximately 6% of all 
households and 15% of people across the countries surveyed experienced financial 
catastrophe1 due to out-of-pocket (OOP) payments for medicines (Priyanka et al., 
2010). OOP payments for medicine is projected to double by 2030 (Barraclough and 
Clark, 2011, McIntyre et al., 2006). The need to reduce the financial impact on 
individuals is paramount thus reducing medicine waste is essential. 
Wastage of medicines through medicine expiry is a global challenge. In the United 
States of America and Switzerland, wastage rates have been estimated at 16% and 
29% respectively, with more than $1 billion (Toerper et al., 2014) and $436 million  
(Vogler et al., 2014) lost per annum respectively. Studies looking at revenue loss due 
to expired medicines are few in developing countries. However, in Uganda in 2006, 
revenue loss due to expired medicine was estimated to be at least $550,000 for that 
year (Mwesige, 2006).Though specific published costing data are limited in South 
Africa, in 2014, the Viennese Sickness Fund reported that medicines worth $8.8 million 
had expired in the country (Vogler et al., 2014). Furthermore, a few local studies in 
                                                          
1 Catastrophic health expenditure- health care expenditure resulting from severe illness/ injury that usually requires prolonged 
hospitalisation and involves high costs for hospitals, doctors and medicines leading to impoverishment or total financial collapse 
of the household 
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South Africa conducted at provincial level (Motlanthe, 2010), district level (Tayob, 
2012) and hospital level (Dunga, 2013), have pointed to the high levels of wastage 
due to medicines expiring that may be curtailed with improved management and 
efficient inventory coordination. For example, between July 2007 and June 2008, 
medicines worth $66 000 expired across 41 hospitals in the Limpopo province that is 
an average of 0.07% of pharmaceutical expenditure per month (Motlanthe, 2010).  
 
There are different factors at different levels of the medicine supply management 
(MSM) cycle that may contribute to the expiration of medicine: manufacturer, supplier, 
organisation and user level factors (Dias, 2011). All levels are involved in ensuring 
availability of medicine to patients, however the longer the supply chain, the higher the 
risk for medicines expiring (Dias, 2011). Most of the operational studies conducted in 
South Africa have investigated causes of medicines expiring within the context of the 
pharmaceutical management cycle (figure 1) (Dunga, 2013, Motlanthe, 2010, Tayob, 
2012). 
 
 
 
 
 
 
 
 
 
 
Figure 1: The Pharmaceutical Management Framework (Embrey, 2011) 
 
Nakyanzi and colleagues (2010), Dunga, Motlanthe and Tayob have identified 
procurement and use as the most critical components in the cycle to avoid medicines 
expiry. In the South African context selection is a function at the national level, while 
procurement and use are the main functions at hospital level; strategies may be 
employed to strengthen these functions at this level. In addition, Motlanthe highlighted 
management support as a critical component that contributes to medicine expiry and 
this included lack of internal control measures, lack of training in medicine supply 
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management, lack or inadequate supervision and monitoring of medicine 
management systems. The need for accurate and reliable data at hospital level (focus 
of study) that feed into higher levels at district then province is particularly important 
to make informed decisions related to procurement and use, which is vital to ensure 
uninterrupted supply of medicines. Planning and coordination have been identified as 
the most critical components of organisation level (hospital level) factors which may 
result in medicines expiring. For example, in Tanzania the lack of planning, 
coordination, monitoring and evaluation (M&E) resulted in a lack of medicines at the 
regional level and this caused medicine stock out at the organisational levels in all 
hospitals and clinics; unexpected demand of medicines that were not accurately 
forecasted for and; inaccurate calculation from the previous orders (Garraoui et al., 
1999). 
 
The abovementioned studies suggest interesting findings in relation to the 
quantification and causes of medicine expiring. However, only one (Motlanthe) 
discussed the extent of revenue loss due to expired medicine and explored possible 
reasons for such loss at a provincial level in South Africa. This study, however, will 
explore these within a tertiary hospital context; what is here considered to be the 
organisational context.  
 
This study, based within a hospital (“the organization”), will explore organizational-
level factors that contribute to the expiration of medicines. At this level, such factors 
include M&E, labeling, coordination, medicine procurement, selection, distribution, 
and use and storage, as well as human resources (Dias, 2011). Even with an excellent 
supply chain, ‘upstream’ of the organization, medicines may still expire due to 
inadequate management, the duration of end-to-end supply or ineffective supply 
management at the level of the organization. The following figure (figure 2) describes 
the supply chain of medicines in Gauteng Province in South Africa (the province in 
which this research is located): 
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Figure 2: The pharmaceutical supply chain in Gauteng Province 
(Kachwee and Hartmann, 2013) 
This study also estimates the potential revenue loss due to expired medicines within 
the hospital setting. Such information is critical to determine whether the available 
resources are currently being used efficiently in light of South Africa’s healthcare 
resource scarcity (World Health Organisation, 1998). Moreover, information on why 
medicines expire is important to institutionalise remedial actions to reduce this 
wastage. 
 
1.2 Background 
 
In South Africa, 80% of the population is dependent on the public sector to provide for 
their healthcare needs (Price, 2014). Government allocations and donor funds, 
predominantly Global Fund, are a major source of financing for medicines supply in 
South Africa (Price, 2014). Yet, there is concern about rising healthcare costs, with 
budgets becoming more restrictive and slow economic growth rates of 3.3% in 2014 
and 3.5% in 2015 (Nene, 2015). In developing countries, medicines comprise the 
second largest single healthcare cost after human resources (Dias, 2011). More than 
30% of the world’ population lack the medicines they need and this figure increases to 
50% in Africa and Asia (Tumwine, 2010). In these contexts, access to medicines is 
often used as a proxy for a good healthcare management system (Tayob, 2012). 
Therefore, persistent and inequitable access barriers to medicines further highlight the 
need to continuously identify strategies to reduce avoidable waste in the form of 
medicines expiring in order to retain confidence in the health system by both patients 
and healthcare providers, and improve equity in access overall.  
 
National Health Provincial 
Health 
Suppliers 
Medical 
Supplies Depot 
Gauteng 
Hospitals 
(organisation level) 
Consumers / 
Patients 
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In South Africa, public health facilities, including pharmacies, are guided by the Public 
Financial Management Act (PFMA no1 of 1999) of the country. The document 
highlights the responsibilities associated with ensuring that proper control systems 
exist for assets and that preventative mechanisms are in place to eliminate theft, loss, 
wastage and expiry (Public Finance Management Act, 2009). The PFMA emphasises 
the need for public institutions to avoid unauthorised, fruitless expenditure where 
expired stock will be recognised as wasteful expenditure by the Department. Whilst it 
is relatively easy to estimate the direct costs of expired medicines, which are defined 
as the actual value of the medicines that expire; it is more difficult to quantify the 
indirect and intangible losses. The latter include the costs of loss of life when 
individuals fail to access life-saving medicines or loss of productivity when individuals 
cannot work due to prolonged illness (Kumarasamy et al., 2007, Xu et al., 2003). 
However, with  efficient inventory control, any excess stock identified early can be 
distributed where it is most needed, before it expires, to reduce the economic losses 
(Public Finance Management Act, 2009).  
 
The pharmacy is an integral part of any hospital or health facility. A holistic healthcare 
service can only be provided if the pharmacy is functioning effectively and efficiently 
(Dunga, 2013). The overall objectives of a public healthcare pharmacy are to promote 
the rational use of medicines by prescribers, dispensers and patients; and to ensure 
good dispensing and prescribing practices. Pharmacies should aim to ensure safety, 
efficacy and quality of medicines; ensure availability and accessibility of medicines to 
all patients at the facility; and to offer appropriate pharmaceutical services to patients 
of the hospital (Pharmacist, 2012). 
 
To this end, in the hospital study site of this research, an operational exercise was 
undertaken in January 2011 to identify and remove all expired medicines from the 
shelves. Pharmacists and pharmacy assistants visited all inpatient wards, outpatient 
departments and the pharmacy itself to identify and remove all medicines that had 
expired or that would expire within six months. Subsequently, it has become practice 
to conduct monthly medicine audits to ensure the early identification and removal of 
expired medicine at the hospital. However, once data are collected no further 
evaluations are conducted to identify strategies to inform future interventions to avoid 
medicines from expiring. 
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1.3 Statement of the problem 
 
Medicines and their management are an important health system function to improve 
and maintain health, however the lack and wastage of essential medicine is still one 
of the most serious public health problems (Tumwine, 2010). Shortages of essential 
medicines are experienced in South Africa especially among chronic patients who may 
experience complications or fatalities (Fokazi, 2012). Reducing medicine expiry is 
therefore important in contexts of shortages of medicine. Evidence in Africa, as is the 
case in Uganda (Mwesige, 2006) has shown the cost implication of expired medicines. 
Globally, expired medicines contribute to the poor performance of health systems, 
driving up costs and reducing access to quality care for patients (Dias, 2011). 
Conversely, well managed and controlled medicine supplies that keep wastage to a 
minimum, may strengthen health system functioning and contribute to public health 
and trust in healthcare (Dias, 2011, Jha and Roy, 2005, Kachwee and Hartmann, 
2013). Although efforts are underway to strengthen South Africa’s health system 
through the reengineering of primary healthcare (PHC) and the piloting of a National 
Health Insurance (NHI) System (National Department of Health, 2015) – which aim to 
strengthen supply chain management and deliver healthcare, including medicines 
through a district-led system, little is known of the economic impact related to, and 
reasons for, the expiry of medicines in the South African context. Reform of medicine 
management, as a health system building block, is needed in an effort to holistically 
strengthen the system. 
  
1.4 Research Question 
 
How much revenue is lost due to expired medicines and what are the reasons for 
this loss at one tertiary public sector hospital in Johannesburg, South Africa? 
 
1.5 Justification of the study 
 
Poor governance in the pharmaceutical sector is believed to significantly contribute to 
challenges in pharmaceutical management at different levels of the health system 
(Anello, 2006). Inefficiencies in medicine management at health facilities have resulted 
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in multiple forms of irrational practices and waste, in particular medicine expiry. In 
2011, expired medicines in South Africa were estimated to be worth R3.4 million, R2.3 
million originating in Gauteng Province (Fokazi, 2012). In the study site for this work, 
an estimated R250, 000 revenue was lost due to medicines expiring in 2010 
(Pharmacist, 2012). This information identified a gap in analysing revenue loss due to 
medicine expiry and possible reasons for such loss, and thus provided the stimulus 
for this study.  
Reducing medicine product waste is an effective strategy to decrease costs, since it 
does not affect patient care (except in terms of medicine availability), or place limits 
on the use of higher-cost medicines (Dias, 2011). As a technical exercise, budget 
evaluations are ideally carried out on current expenditure to ensure current stock is 
better used. Expired medicine is not the ideal place for budget evaluations as the 
medicine is no longer usable, however its contents may assist policy makers in 
identifying high waste medicine products and explore cost saving measures. In 
addition, the information provided may enhance decision-making in financial and 
inventory management thereby informing strategies to reduce cost, especially at this 
vital phase as South Africa is moving toward a NHI, which will focus on efficiency and 
effectiveness (National Department of Health, 2015). 
 
1.5.1 Aim of the study 
 
The aim of this study is to describe the economic impact related to, and reasons for, 
the expiry of medicines at a large urban hospital in Johannesburg, South Africa from 
January 2011 until June 2014. 
 
1.5.2 Study objectives 
 
a. To describe the trend of expired medicine at a large urban hospital in 
Johannesburg, South Africa from January 2011 until June 2014 
b. To determine the average revenue loss due to expired medicine at a large urban 
hospital in Johannesburg, South Africa from January 2011 until June 2014. 
c. To explore possible reasons for revenue loss due to expired medicine at a large 
urban hospital in Johannesburg, South Africa from January 2011 until June 2014.   
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CHAPTER 2: LITERATURE REVIEW 
 
2.1 Introduction 
 
Medicine management is a system of processes and behaviours that determines how 
medicines are ultimately used by or available to patients. In addition, it is an important 
function for health service delivery to control the costs of medicines, as well as reduce 
morbidity and mortality, and has a special importance for five main reasons: 
a. Medicines save lives and improve health outcomes; 
b. Medicines promote trust and participation in health services; 
c. Medicines are costly: medicine expenditure represent the largest expenditure 
over which ministries have yearly discretionary control, which make medicines 
both important and vulnerable to availability of public funding; 
d. Medicines are different from other consumer products: medicines do not 
conform to the market demand and supply concept. The patient does not 
choose the medicine prescribed nor is the average prescriber equipped to 
independently assess the quality, efficacy or safety of each new medicine; and 
e. Improvements in the supply and use of medicines are possible (Barraclough 
and Clark, 2011). 
Management is the process for ensuring organisational goals are met through 
continuous monitoring and effective management of resources (Garraoui et al., 1999). 
The management function as a whole points to the need to examine the 
pharmaceutical management process, in particular the planning and organisation that 
is required for effectively managing medicines. Effective management is the 
foundation for ensuring the effective medicine management that is required for the 
reduction of waste, coupled with transparent leadership and governance to ensure 
accountability. Challenges in effective medicine management highlighted by 
managers include difficulty in achieving financial sustainability, improving efficiency 
and reducing pharmaceutical waste (Embrey, 2011). Wastage can interfere with the 
effective functioning of any pharmaceutical system. It may highlight inadequacies, 
such as a lack of control, of management both in the pharmacy and at an institutional 
level which may result in inventory and financial waste.  
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The overestimation of medicine orders to ensure sufficient stock is a major contributor 
to wastage of medicines. For example, in a Central American country, inventory 
records have shown cases of the intentional overstocking of products due to theft 
(Daniel, 2011a). In a Southeast Asian country, losses caused by wastage are 
estimated to be more than 30% of the annual medicine budget and; in another country 
in Central Africa, a hospital pharmacist was seen to routinely allow for losses of 
approximately 90% on certain medicines when placing an order to ensure that 
sufficient stock was received (Daniel, 2011b). But as these cases suggest, there may 
be multiple reasons, including efforts to avoid stock outs that may weaken 
accountability which may be complex. Knowledge of why wastage occurs may allow 
for a more nuanced engagement with the problem. 
2.2 Pharmaceutical Management 
 
Organisational level factors such as monitoring and evaluation, coordination, 
communication, information management as well as human resources are embedded 
in the entire pharmaceutical management framework. The organisational level factors 
are interlinked and have knock-on effects throughout the pharmaceutical management 
cycle as illustrated in Table 1: 
Table 1: Organisational level factors on pharmaceutical management framework 
Pharmaceutical 
Management Framework 
Description of causes and effects Organisational level factor 
Selection  Change in treatment policy without 
comprehensive planning on 
implementation impacts 
Communication with knock-on effects on 
all other  organisational level and 
pharmaceutical management components 
Procurement Inappropriate demand planning and 
quantification. Ensure availability of 
medicine 
Coordination with knock-on effects on all 
other organisational level and 
pharmaceutical management components 
Distribution Interrupted supply of medicines due 
to contract start and end dates that 
are not in effectively coordinated 
Coordination with knock-on effects on all 
other  organisational level and 
pharmaceutical management components 
Use Prescribing practices in the public vs. 
private sector. The lack of enforcing 
the use of standard treatment 
guidelines 
Monitoring and evaluation with knock-on 
effects on all other  organisational level 
and pharmaceutical management 
components 
 
Management support 
systems 
Lack of formal training in medicine 
supply management 
Human resources 
Inadequate data which impact 
decisions on procurement and 
budgets 
Information management 
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The pharmaceutical management framework is the foundation for pharmaceutical 
services. The framework consists of four main functions: selection, procurement, 
distribution and use. These aim to ensure availability of medicines to patients (Embrey, 
2011). Each major function builds on the previous function and leads logically to the 
next. At the core of the pharmaceutical management cycle (Figure 3) are management 
support systems, which include the planning and organisation of services, financing 
and financial management, information management, and human resource 
management (Embrey, 2011). These management support systems should 
strengthen the pharmaceutical management cycle. As part of management support, 
managers at all levels of an organisation should be concerned with effectively using 
resources, as financial sustainability is only achieved when expenditures and financial 
resources balance and are sufficient to support a given level of demand (Dias, 2011, 
Embrey, 2011). 
In South Africa, pharmacists are responsible for the management of medicines and to 
oversee the complete medicine distribution cycle - from the prescription according to 
the diagnosis, through to the choice of medicine, dispensing, preparation and 
administration of the medicines (Nsovo et al., 2015). Medicines stored in hospital 
wards remain the responsibility of the designated pharmacist of the hospital and 
should be managed in accordance with the Medicines and Related Substances Act, 
Act 101 of 1965, as amended Act 90 of 1997 (Health Professional Council of South 
Africa, 1997). Wastage may occur at each point within the cycle, however interventions 
targeting the organisational level factors affecting procurement and use components 
of the cycle may minimize wastage at the facility. Each function and its related 
components will be discussed in this section. 
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Figure 3: The Pharmaceutical Management Framework Updated (Embrey, 2011). 
In South Africa, the National Drug Policy (NDP), which forms part of the National 
Health Policy, aims at reducing waste by ensuring the availability of appropriate quality 
medicines in order to serve the healthcare needs of citizens by improving efficiency 
and cost-effectiveness of the pharmaceutical industry (National Department of Health, 
1997). One of the main objectives of the NDP is to achieve access and equity through 
effective management of the selection, procurement, distribution and use of medicines 
and medical supplies. The NDP also provides guidelines to pharmacies. These include 
methods that define minimum and maximum stock levels, guidelines on systematic 
stock rotation and handling of expired and obsolete stock (National Department of 
Health, 1997). 
 
2.3 Selection  
 
The selection of essential medicines is one of the core principles of a national medicine 
policy because it helps to set priorities for all aspects of the pharmaceutical system 
(WHWorld Health Organisation, 2010). Essential medicines consist of medicines that 
are deemed to satisfy the healthcare needs of the majority of the population. They are 
carefully selected and a large part of their selection involves assessing epidemiological 
•Inventory Management
•Demand Planning
•Quantification
•Supply chain
•Essential Medicine
•Standard Treatment 
Guidelines
•Prescribing
Use Selection
ProcurementDistribution
Management 
Support 
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trends in a specified population, thereby identifying which medicines should be 
available at each level of care on the basis of standard treatment guidelines (STGs) 
(World Health Organisation, 2002). They are selected with due regard to public health 
relevance, evidence on efficacy and safety, and comparative cost-effectiveness 
(WHWorld Health Organisation, 2010). Thus, limiting the selection of essential 
medicine may lead to improved supply, rational medicine use and reduced cost (Dias, 
2011). Most medicine budgets in developing countries are below $30 per person per 
year, with 38 countries allocating less than $2 per person per year (World Health 
Organisation, 2002). Overuse or incorrect use of medicines whether essential or non-
essential, result in excessive spending on medicines for both patients and the 
healthcare system which may ultimately waste financial resources (Chalker, 2011). 
 
The basis of medicine selection in South Africa is guided by the WHO Essential 
Medicine List (EML) model (Dukes et al., 1997). Each province/state and area is 
different and the priorities may differ considerably, though following the WHO model, 
the decision about which medicines will be classified as essential is conducted at the 
National level (Embrey, 2011). 
There are multiple reasons to support the use of limited essential medicines (Olson, 
2011): 
a. Basic health services, including medicines be accessible to everyone; 
b. The public sector cannot afford to supply all medicines that are available on the 
market; 
c. Prescribing patterns are influenced by preferences that may differ among 
prescribers and when the limited number of medicines are available according 
to the STGs, then it may increase their confidence in the health system;  
d. Concentrating procurement and logistic efforts on a limited number of 
medicines with large quantities may result in economies of scale; 
e. Increased patient education and efforts to provide medicine information may 
improve rational prescribing and use (Brook, 2011, Chalker, 2011, Goosens et 
al., 2005); and 
f. Improved effectiveness and efficiency reduce healthcare costs, in particular 
medicine cost and more funds are available for alternative more expensive 
medicines. 
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The EML has been shown to improve the quality, cost-effectiveness and availability of 
medicine for healthcare delivery when combined with proper procurement policies and 
good prescribing practices (WHWorld Health Organisation, 2010). Though the benefits 
to having an EML are known, nearly 40 years since the introduction of the WHO EML, 
only a few studies have investigated its impact (Duong et al., 2015). For example, 
approximately 80% availability of medicines was found in Sudan and Burkina Faso 
(Bazargani et al., 2014). In contrast, a study by Cameron et al., showed that low and 
middle income countries still experience low availability of generic medicines and high 
prices paid by consumers despite national EML policies (Cameron et al., 2009). In 
Nepal, approximately 50% of the total medicine used by patients in one study was 
related to inappropriate prescribing of medicines that are not on the EML (Breman et 
al., 2006). In countries where an EML exist, it serves as a basis for public procurement 
of medicines which should always be available to ensure access to priority medicine 
especially for the poor (Bazargani et al., 2014). 
Various weaknesses were found in a recent evaluation of the EML in India, including 
improper selection of medicines, improper principles of medicine selection, non-
alignment to National Health, errors in medicine strength and incomplete medicine 
information (Manikandan and Gitanjali, 2012). These errors directly impact on the 
selection, procurement and use of medicines which increase medicine wastage. The 
study further highlighted that expenditures on non-essential medicines, such as 
multivitamins or cough mixtures, drain limited financial resources that could otherwise 
be allocated for more essential products, such as vaccines or antibiotics (Barraclough 
and Clark, 2011). 
 
In South Africa, the National Essential Medicines Committee (NEMLC) consisting of 
multi-disciplinary technical experts are responsible for the selection of medicines for 
the EML and development of STGs for use by prescribers in the public sector (National 
Department of Health, 2012). Each province has a Pharmaceutical and Therapeutics 
Committee (PTC) that contribute to the selection and promotion of medicine use. 
STGs exist to assist prescribers on specific treatments for specific clinical problems. 
In addition to listing essential medicines, the EML indicates at which level of care 
specified medicines should be used. There is also a formulary system that comprises 
of a formulary list which is based on the EML, and a formulary manual which contains 
summary information on each medicine on the formulary list (National Department of 
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Health, 2012). STGs and the EML are continuously reviewed and updated (National 
Department of Health, 2012). Therefore, there is need to manage and monitor the 
process to avoid medicine wastage if any changes occur. 
 
South Africa carries the highest burden of the human immunodeficiency virus (HIV) in 
the world, with an estimated 6.1 million of its population HIV positive and more than 2 
million people on antiretroviral treatment (ARV) (UNAIDS, 2013). Over the past five 
years, an overall increase in life expectancy has been realised, which is mainly 
attributed to the country’s response to combating the HIV/AIDS pandemic (National 
Department of Health, 2010). The South African ARV Tender is the largest of its kind 
in the world, with increased competition and economies of scale enabling the 
government to significantly reduce the cost of ARVs thereby allowing more patients to 
receive ARVs and have improved health outcomes (National Department of Health, 
2010). A growing proportion of people living with HIV/AIDS also struggle to cope with 
tuberculosis (TB) and one or several non-communicable diseases (NCDs) such as 
diabetes, hypertension, cancer and stroke, particularly as they age (Geneau and 
Hallen, 2012). The need to ensure that medicines are available remains a priority 
especially where non-adherence may be fatal. Efforts to reduce waste especially in 
the form of improved management of medicine expiry is paramount as medicine costs 
are expensive. 
 
2.4 Procurement 
 
Inventory management is the function of supply management that aims to provide 
sufficient stock of medicines at the lowest costs possible (Dias, 2011). A well-
functioning supply management system promotes: 
 Good inventory records and procedures, which is the basis for coordinating the 
flow of products; 
 Protection against theft, corruption and expiry; and 
 Necessary stock management and quality (Dias, 2011). 
Quantification is the main component of inventory management and the first step in 
the procurement process. It is defined as the process of estimating quantities and 
costs of products required for a specific health programme during a specific period 
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and determining when deliveries of the products should be delivered to ensure 
uninterrupted supply (Dias, 2011). The procurement system is a major element of 
pharmaceutical availability and related cost (Reuter, 2006). Effective procurement 
management enables the healthcare provider to provide the right medicine of the right 
quality to the right patient at the right time, in the right quantity at a reasonable cost 
(Chalker, 2011).  
 
The quantification of medicine required is conducted to limit stock shortages, minimize 
excess stock and wastage and to contribute to the provision of quality healthcare. The 
basis for calculating the appropriate quantity of medicines to be ordered that are within 
pharmacists’ control is average consumption, quantity on hand and re-order level 
(Dukes et al., 1997).  By monitoring the rate of medicine consumption, the healthcare 
provider can forecast future medicine requirements with accuracy, although there may 
be challenges. For example, in Tanzania, medicine shortages resulted from 
unexpected demand, as well as inaccurate consumption data and trends (Barraclough 
and Clark, 2011). Any improvement made at facility procurement management may 
benefit the whole medicine supply system; however the reverse is also true. If too 
much medicine is ordered, it will result in overstocked items which may expire before 
use – leading to wastage -  and if too little is ordered, essential medicines may not be 
available when needed (Barraclough and Clark, 2011).  
 
Improved medicine availability as a result of better quantification has been seen 
globally, including more recently, in Kenya and Namibia (Dias, 2011). Though various 
methods for quantification exist, the quantity and type of medicine required will depend 
on the disease pattern in the area served by the health facility. Despite availability of 
numerous tools for the management of medicines, none of these specifically target the 
health worker who has had no formal training in medicine logistics and supply 
management systems and yet is expected to participate in the management process 
(Jha and Roy, 2005). Being trained in medicine supply management (MSM) and 
actively dispensing with appropriate licencing has also been noted as a gap. For 
example, a local study conducted at PHC level among nurses found that though 45% 
acknowledged being trained in MSM, only 16% had the appropriate dispensing 
licencing (Tayob, 2012). 
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Medicine shortages is a global challenge affecting both developed and developing 
countries (Marshall, 2014). The shortage of essential medicine impact the access and 
availability of health services to patients which may result in poor health outcomes 
(Bazargani et al., 2014, Duong et al., 2015, Matse, 2005). The South African 
pharmaceutical sector, guided by the National Drug Policy (1997), currently uses a 
centralised tendering system to procure essential medicines and medical supplies for 
the public sector (National Department of Health, 1997). The aim is to enable the 
majority of the citizens, especially those from previously disadvantaged communities 
to have access to medicines. Thus, if the quantities issued to facilities are not a true 
reflection of demand, then the estimates transmitted to the central level may be 
incorrect. In addition, the inaccurate quantification estimates from facilities, districts 
and provinces may influence the tendering process. Therefore, disrupt the entire 
system and may result in the following problems: 
 Inaccurate estimates for the tender process; 
 Negatively affect the allocated budget; and 
 Loss of confidence in the health system by prescribers and patients due to stock 
outs (National Department of Health, 1997). 
 
2.5 Distribution 
 
The success of the pharmaceutical management cycle is dependent on the ability to 
reliably and consistently supply medicines to health facilities at all levels of the health 
system. The consequence of supply interruption can be catastrophic, especially for 
medicines where non-adherence can be fatal for individuals while increasing 
resistance - such as antibiotics and ARVs (Clark, 2011). For example, distribution of 
TB medicine was highlighted as a challenge in Nepal due to the topography and 
vastness of the area. Medicines were distributed from central level to regional stores 
then district usually by vehicle or plane. Thereafter, medicines were carried by bicycle 
or on foot,  weather permitting, which impacted on the availability of consistent 
medicine supply (Clark, 2011). 
 
The medicine supply chain is unique as it consists of large, extended global pipelines, 
requires high levels of product availability and has high uncertainty in supply and 
demand (Tayob, 2012). The medicine distribution process should be treated as an 
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important function of the health system to ensure delivery of items to the intended 
destination. Medicine distribution through improved management and increased 
investment of resources to achieve uninterrupted supply may improve medicine 
availability (Barraclough and Clark, 2011, Clark, 2011). Restrictive resources may be 
more complex in ensuring the availability and distribution of certain medicines. For 
example, insulin for type-1 diabetic is expensive and is purchased through country 
budgets that are already inadequate, whereas ARVs are mainly funded through the 
Global Fund (Beran et al., 2016). According to Matse, more than 70% of procurement 
and distribution processes are compromised due to inadequately trained staff. 
Professionals often lack basic knowledge on management of medicines supplies but 
are expected to ensure proper purchase, utilisation and appropriate use of those 
medicines (Matse, 2005). Adequate training of staff on MSM, knowledge of 
procurement and distribution processes especially its importance in ensuring 
uninterrupted supply of medicines is one of the key aspects to reducing waste. 
 
There are different approaches that can be used to address resource wastage in the 
form of medicine expiry. First Expiry First Out (FEFO) is a distribution procedure that 
ensures that the stock with the earliest expiry date is distributed and used before an 
identical stock item with a later expiry date is distributed or used (World Health 
Organisation, 2005). When implemented accurately, FEFO assists with stock 
management and reduces the chances of medicine expiring. First In First Out (FIFO) 
is also be useful when no expiry dates on medicine exist, the stock should be 
distributed on a first priority basis. These two terms may cause some confusion, 
however FIFO does not mean that stock that came first will expire first, hence the 
importance of effectively managing stock to minimise the risk of expiry. Even though 
not the main focus of study, it is also important to acknowledge that storage facilities 
at health facilities and depots are a vital part of the supply chain, necessary to ensuring 
that stock is not spoilt.  
The current public sector pharmaceutical supply chain in South Africa has seen 
challenges related to capacity constraints and supply issues which result in stock outs 
of essential medicine at health facilities (Tayob, 2012). The Stop Stock Outs Project 
(SSP) conducts annual surveys on the availability of ARV and TB medicines at 
facilities across the country. The SSP is useful as it is a mechanism that holds 
management at all levels of care accountable for patient health outcomes. The 
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provincial depots are constrained by aging infrastructure not designed for the current 
population and associated disease burdens, combined with the inappropriate 
processes and systems (Dunga, 2013). This has resulted in high wastage levels, 
inability to supply medicines to facilities on time and non-payment to suppliers which 
reduce the overall availability of medicine to the population. In addition, the overall 
process has further been challenged by the lack of visibility at all levels of care with 
regards to the elements of supply chain, thus making forecasting for contracts almost 
impossible which further negatively affect supply issues (Pharmacist, 2012). 
 
2.6 Use 
 
Rational medicine use requires that medicines are prescribed for a particular patient 
after proper diagnosis of a health problem (Chalker, 2011). The main aspect of rational 
medicine use includes appropriate diagnosing, prescribing, dispensing, and proper 
consumption by the patient (Chalker, 2011). Data from developing countries indicate 
that fewer than 40% of patients are treated according to STGs (WHWorld Health 
Organisation, 2010). Irrational medicine use occurs globally at all levels of care. For 
example, the overuse of antibiotics is not a problem limited to developing countries; 
According to Goosens et al (2005) France uses over three times more antibiotics per 
patient care than does Netherlands. 
 
Irrational medicine use may involve cases where poorly trained prescribers, prescribe 
irrationally. For example in Kenya a study found inadequately trained prescribers were 
a major contributor to irrational medicine use (Chalker, 2011). Similarly, a study 
conducted in Zimbabwe that evaluated practices of dispensing prescribers found that 
dispensing doctors prescribed 35% more medicine than non-dispensing doctors 
suggesting irrational prescribing (Trap, 2003). According to Matse, irrational 
prescribing constitutes 15% of losses that occur in the supply chain in South Africa. 
Policy makers such as WHO originally hoped that the availability of STGs would 
change irrational prescribing patterns (Chalker, 2011). However, it has become clear 
that circulating STGs to all prescribers is not sufficient to see improvement in 
prescribing patterns. In addition, patients may use medicines irrationally by collecting 
treatment even when they are not ill, or they may accumulate more medicines than 
required to avoid anticipated facility stock out periods in future (Bazargani et al., 2014).  
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The financial and medicine waste related to irrational prescribing may not be 
monitored and effectively communicated to prescribers and patients (Embrey, 2011). 
 
2.7 Medicine Wastage 
 
Budget restrictions are experienced globally, but more so in public sector hospitals 
where there is significant focus on improving workflow and reducing expenses 
(Agnelly, 2014). One of the key criterion in evaluating healthcare systems is 
expenditure (Kerr and Romine, 2012). Improving inventory efficiencies and reducing 
medicine waste, while enhancing patient care remain a challenge to hospital 
pharmacies (Agnelly, 2014). Studies conducted in England and Spain estimated a 
gross annual prescribed medicine wastage of more than $400 million and $9000 
respectively (Coma et al., 2008, Langley et al., 2005). In other studies, though real 
value could not be assessed, two indicated an enormous burden on pharmaceutical 
budgets, caused by wastage (Mackridge and Marriott, 2007, Cameron, 1996).  
 
Around the world, expiry costs are often 3% to 5% of pharmaceutical inventory per 
annum (Dias, 2011). However, in Spain, more than 50% of medicines evaluated in 
community pharmacies had expired (Coma et al., 2008). Similarly, a study conducted 
in Nigeria to assess availability of ARVs in treatment centers found that 64% of the 
facilities had expired ARVs worth more than $146 000 (World Health Organisation, 
2003). The national figure for expiry reported in Ethiopia in 2003 was as high as 8% 
(Tadeg et al., 2014). In South Africa, while expiry costs according to the Gauteng 
Provincial policy should not exceed 1% of a facility’s annual budget (Pharmacist, 
2012), the cost of expired medicine in one clinic in a study conducted by Tayob was 
as high as $8 000, which is equivalent to the average monthly medicine expenditure 
for one PHC clinic (Tayob, 2012). Similarly, revenue loss across 41 hospitals in 
Limpopo province was more than $66 000, of pharmaceutical expenditure, i.e an 
average of 0.07% a month (Motlanthe, 2010). 
 
Medicine wastage, in particular expiry costs, may serve as a proxy for ineffective 
inventory control and management of financial resources at public health facilities. 
Even though tools are available for effectively monitoring medicine procurement, use 
and financial resources, skills and capacity are important pre-conditions. Monitoring 
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processes may be compromised due to inadequately trained staff or processes that 
do not take enough account of the local context. The lack of accountability in managing 
medicines has exposed the public healthcare system in South Africa to wastage, which 
may directly impact availability of medicines especially to the poor, who are mostly 
affected by such inefficiencies (Motlanthe, 2010).   
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CHAPTER 3: METHODOLOGY 
__________________________________________________________________________________ 
 
3.1 Study Design 
 
This mixed methods study included both quantitative and qualitative components, set 
in a large tertiary hospital in Johannesburg. The quantitative part consisted of a 
retrospective data extraction of medicines that were recorded as expired during the 
period 2011 to mid-2014. The qualitative part comprised semi-structured in-depth 
interviews with key actors to explore the reasons for the expiration of medicines. In 
addition, informal observations were conducted across the duration of the fieldwork 
and recorded in a researcher diary. The quantitative and qualitative components were 
undertaken concurrently and the data were integrated during the interpretation phase 
(Creswell, 2006). Using a triangulation approach, the methods were mixed in 
interpretation and analysis, to contribute to a more holistic understanding of the 
problem (Creswell, 2006). 
 
3.2 Study Site 
 
The study was conducted at a large urban tertiary hospital in Johannesburg, Gauteng, 
South Africa. The hospital provides medical and surgical inpatient and outpatient 
services. The hospital has 347 approved beds and an average medical intake of 45 
patients per day. The hospital is home to one of the largest HIV/AIDS treatment clinics 
in the country, which currently maintains more than 15,000 adult patients on 
antiretroviral (ARV) therapy. At the time of the study, there were 9 pharmacists and 12 
pharmacist assistants. During the study period, expired stock was manually monitored, 
however an electronic medicine management system, Rx Solution®, is currently used 
to monitor expired medicines. 
 
3.3 Study Population and Sample 
 
Quantitative record review of medicine audit 
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The quantitative component of the study consisted of a review of records from a 
medicine audit aimed to remove all expired stock or medicines that would expire within 
six months. These medicines were removed from the wards, outpatient departments 
and pharmacy - and were disposed of or dispensed to the pharmacy outpatient 
department to ensure usage before expiration. The study sample included all the 
records of medicines that expired in the wards, outpatient departments, and pharmacy 
and were recorded at the hospital pharmacy between January 1, 2011 and June 30, 
2014.  
 
In-depth interviews with key actors and observations 
 
The qualitative component of the study consisted of semi-structured in-depth 
interviews with key stakeholders, as well as observation notes made by the 
researcher. Participants included ward managers, pharmacists and pharmacy 
assistants who had been working at the hospital for a minimum of 12 months, and 
were therefore familiar with the medicine management policy. Purposive sampling was 
used to select the 13 participants for the interview. These participants were chosen 
because they occupy positions that are central to medicines management and 
therefore of direct relevance to the study, such as pharmacists and ward managers. 
Sampling proceeded until the point of saturation, that is, when there was reduced 
variability in the information received (Barnes et al., 2012). The staff members were 
asked to participate in an interview to explore possible reasons for medicine expiration, 
and related trend and revenue loss.  
 
The researcher also kept a diary and conducted informal observations in the wards, 
pharmacy and outpatient departments. Observations included practices of packaging, 
storing, naming and recording of medicines. 
 
3.4 Data Collection 
 
Data were collected from July 2014 by the researcher through three mechanisms; i) a 
data extraction tool which included costs to quantify and classify the type of medicines 
that had expired. A pre-existing electronic database that had been set up in 2011 to 
record expired medicines in the different wards was used. However substantial data 
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cleaning was required because certain fields were either omitted or incomplete in the 
original database, ii) semi-structured in-depth interviews to explore reasons for 
medicines expiring, and iii) a researcher diary based on observations to identify gaps 
between policy and implementation. 
a. Data extraction for quantitative information 
The data extraction tool (Appendix A) was developed in Microsoft Excel®. Information 
was compiled on medicines that had expired between January 1, 2011 and June 30, 
2014. The original dataset consisted of the medicine name, expiry date, recorded date, 
unit, expired quantity and unit cost for each item. The dataset was expanded and 
additional information on national stock number (NSN), route of administration, the 
VEN classification according to the provincial formulary, anatomical therapeutic class 
(ATC) code from the WHO classification (Appendix B) and according to the essential 
medicine list classification were manually added. A full list with ATC codes and 
definitions is provided in Appendix B. The hospital medicine formulary edition from 
2014, the Essential Drug List for hospitals and the National Master Procurement 
Catalogue (MPC) were used to classify each medicine. 
The unit cost per medicine expired was recorded using the cost from the year in which 
the medicines were recorded as expired. For records, whose unit cost were unknown 
(four items), the cost in the year which the medicine expired was used. The 2014 year 
records ran up to June. Therefore, the revenue loss was estimated until June 2014. 
The researcher assumed that half the budget and expenditure was used by mid-year 
and proportion loss for 2014 was calculated based on this. The total cost for each year 
was calculated. The unit costs used were from available invoices or price lists from the 
pharmacy as well as the Gauteng medical supply depot (MSD).  
b. Semi-structured in-depth interviews  
Permission to conduct in-depth interviews was requested from the ward managers, 
ward pharmacy champion, pharmacists and pharmacy assistants (Appendices C). 
Copies of the permission letter obtained from the hospital Chief Executive Officer 
(CEO) were shared with all requested to partake in the interviews. The purpose of the 
research was explained and an information sheet (Appendix D) was provided on the 
details of the study. Participants were invited to ask questions about the study before 
an informed consent process was finalised. The interview guide (Appendix E) covered 
the following topics: 
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 Participant qualifications  
 Ordering of medicines 
 Storage of medicines 
 Knowledge of drug management 
 Reasons for medicine expiration 
  
All in-depth interviews were recorded. Participants were interviewed in English; 
however they were also encouraged to use words or phrases from other languages 
where necessary so that nothing of importance was lost. To maintain confidentiality, 
all participants received unique identifiers during data analysis so statements could 
not be directly linked to an individual. Furthermore, the participants interviewed reflect 
persons who directly manage medicines such as pharmacists, pharmacy assistants 
and nurses. 
 
c. Researcher Diary 
The researcher conducted observations immediately after completing each interview. 
The researcher did not act conspicuous nor attracted any attention that made 
observations visible .In addition, interviews were conducted in a private room with only 
one person in each department, no observer effect (McCambridge et al., 2014) was 
noticed.  
3.5 Data Management and Analysis 
 
Statistics included estimate of total value of the expired medicines by therapeutic class 
and EML classification. Whilst trend tests that test for statistical significance to year on 
year changes are important, three years is a short time period on which to conduct 
sophisticated statistical trend analysis (Rosenberg, 1997). However, statistical 
analysis was conducted to determine the average yearly increase in revenue loss over 
the time period of analysis using equation for calculating average rate of change, 
Appendix F. Further, the total value of expired medicines in each year was expressed 
as a proportion of the total pharmaceutical budget and expenditure to give the 
percentage loss in revenue. The latter value was compared across the three years of 
analysis to determine whether there has been a year-on-year proportional increase in 
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revenue loss relative to the provincial threshold of 1% and the annual hospital 
pharmaceutical expenditure. Expenditure was used as it was the most stable indicator 
across the three years, given that the hospital budget was substantially reduced for 
three years over the study period. 
Analysis of in-depth interviews with key actors 
All in-depth interviews were typed in Microsoft Word® and analysed in Microsoft 
Excel®, which was used to help with the coding and thematic content analyses of the 
data. A code book was developed and analysed deductively (i.e.- from ‘pre-
established’ themes drawn from the literature and conceptual framework) and also 
inductively allowing for themes to emerge from the participants themselves. Texts 
were coded across all transcripts and observation notes were drew on as part of the 
analysis. The information was analysed thematically in a systematic way using an 
exploratory approach in order to explore in-depth the reasons why medicines expire 
(Creswell, 2006).  
The quantitative and qualitative data sources were integrated by bringing the separate 
results together in the interpretation of the analysis (Creswell, 2006). 
Data validation, reliability and trustworthiness 
It is important to ensure methodological rigour and data quality to ensure 
trustworthiness of any study, especially when using a mixed methods approach. The 
quantitative data contained in the original dataset were initially captured for another 
purpose. The medicine that were recorded as expired were already disposed of and 
the data could not been validated to ensure accuracy and enhance reliability. 
Therefore, in this study, medicine names and unit costs were corrected during the 
cleaning of data and the MPC was used to accurately insert or compare medicine 
names and unit costs. Calculations were also re-ran to ensure accuracy. The 
qualitative data was collected to support the argument that the inquiry’s finds are worth 
paying attention to. The qualitative data was reduced to themes that describes the 
research question. The qualitative data were read and coded by more than one person 
to enhance the reliability of the information (Noble and Smith, 2015). In addition, 
quotations were used to enhance the trustworthiness and objectivity of the results. 
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3.6 Ethical Considerations 
 
This study posed minimal risk to the study participants (selected ward managers, 
pharmacists, and pharmacist assistants) as information was kept confidential and 
could not be linked to an individual during analysis because unique identifiers (ID) 
were used. Written informed consent for the interview and recording was sought from 
all participants before the interview was conducted. All interviews were conducted in 
an enclosed office at the hospital to ensure privacy. Each participant was assigned a 
study ID number when data was collected and presented. Only the researcher and 
supervisors of the study had access to all the information that were password 
protected and stored in secure cupboards.  
The interviews were conducted during normal working hours, and no payment was 
provided to participants.  Though there were no direct benefits to study participants for 
being included in the study; the hospital and other health facilities in South Africa may 
indirectly benefit as the information may assist with future planning and management. 
Information from the study may be useful to improve planning, monitoring and 
management of medicines.  
Permission to conduct the study was sought from the University of the Witwatersrand 
Human Research Ethics Committee (HREC) (Medical) – M131015 (Appendix G), and 
the hospital. No data were collected until all permissions were been granted. The data 
will be destroyed two years after completion and publication of the research report in 
accordance with ethical guidelines from the HREC.  
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CHAPTER 4: RESULTS 
 
 
This chapter presents the results from both the quantitative and qualitative 
components of the study. Descriptive statistics are presented about the characteristics 
of the expired medicines included Anatomical Therapeutic Chemical (ATC) 
classification they fall under, type of formulation, single highest unit costs and the VEN 
classification of medicines and related expiry costs. Findings from the interviews 
conducted will be presented thematically and observations conducted and aspects 
observed will be drawn upon. 
SECTION A: QUANTITATIVE RESULTS 
4.1 Description of medicines 
A total of 32,368 unit packs of medicines expired over the study period (January 2011 
– June 2014) consisting of 68 different ATC classes.  
Expired medicine by ATC classification  
Antibacterial for systemic use (16%, n=5067) and antivirals for systemic use (15%, 
n=4970) constituted the highest classes that expired, followed by medicine used in 
diabetes mellitus (9%, n=2856) and anti-epileptics (7%, n=2342). Though only 1%, 
(n=337) of muscle relaxants had expired, this class accounted for more than 10% of 
the total cost. 
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Figure 4: Quantity and cost of medicines that expired by ATC classification 
 
Expired medicine by EML classification and formulation 
More than 80% of the medicines that expired were on the EML with antibacterial for 
systemic use (16%, n=5067) and antivirals for systemic use (15%, n=4970) among the 
highest classes that expired. Additionally more than 20% of the medicines were 
injections accounting for the highest unit costs (Figure 5). 
 
Figure 5: Classes of medicines that expired with corresponding cost 
 
Medicine with highest unit cost 
Medicines were ranked by unit cost and Table 2 depicts the top five expired medicines 
with highest unit costs. 
Table 2: Medicine with the highest unit costs 
Medicine name Unit cost (ZAR) 
Streptokinase for injection 1500 000IU/vial; 1’s R3 147 
Dantrolene sodium for infusion 20mg/70ml; 1’s R1 604 
Desmopressin injection 4mcg/ml; 1ml; 1’s R   832 
Immunoglobulin human injection; anti-rabies; 
ampoule;150iu/ml'2ml; 1’s 
R   592 
Sodium Polystyrene Sulphonate Powder; 454g R    573 
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Top 5 highest single expired medicines 
The Ofloxacin injection value of medicines that expired, accounted for more than 10% 
(R92 507) over the study period, followed by Dantrolene Sodium for infusion (9%, R82 
848) and Acetylcysteine Injection (7%, R59 763). 
Figure 6: Single highest top 5 medicines that expired with corresponding cost 
 
Medicines were grouped according to their Vital Essential Non-essential (VEN) 
classification. More than 50% of the medicines that expired were vital (Table 3) 
Table 3: Total medicines expired by VEN classification  
VEN Classification Quantity Value Expired % of value 
expired 
V 21 066  R433 351  52% 
E    5 313  R162 253 19% 
N    5 989  R242 425 29% 
Total  32 368 R838 029  
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4.2 Total Value Expired over the Study Period  
The estimated total value of expired medicine for the study period was R838 029; an 
estimated annual revenue loss of 0.6% of the hospital’s total pharmaceutical 
expenditure for the period January 2011 to June 2014. The average increase in 
percentage revenue loss over the study period is estimated to be 72%.  
 
Table 4: Total value of expired medicines over the study period (January 2011-
June 2014)  
Year Total value of 
expired 
medicines 
Total 
Pharmaceutical 
Budget  
Total 
Pharmaceutical 
Expenditure 
% loss as 
proportion 
of budget  
% loss as 
proportion of 
expenditure 
2011 R196 197 R13 598 000 R39 705 098 1.4% 0.5% 
2012 R329 161 R  9 276 000 R38 204 549 3.6% 0.9% 
2013 R117 862 R11 382 000 R46 902 168 1.0% 0.3% 
2014 R192 8092 R17 830 0003 R24 506 1624 1.1% 0.8% 
 
Overall, these results, emerging from analysis of the three-year database of expired 
medicines in the hospital, quantify the type and extent of revenue that was lost due to 
expired medicine over the study period. On the one hand too many vital medicine on 
the EML expire, but at the same time it is not surprising, given that this is the pool of 
medicines that should be available. However, any amount of wastage lost is a direct 
financial loss to the facility. To explore reasons for medicines expiring, that is, the 
‘hows’ and ‘whys’ (Creswell, 2006) of these trends, qualitative interviews and 
observations were conducted with actors directly involved in the management of 
medicines in the hospital. 
 
 
 
                                                          
2 Revenue loss up to June 2014 
3 Half the budget shown as data on expired medicines for 2014 ran up to June 
4 Half the expenditure shown as data on expired medicines for 2014 ran up to June 
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SECTION B: QUALITATIVE RESULTS 
 
Interviews were conducted with key actors within the hospital to explore the reasons 
for medicines expiring. Thirteen interviews were carried out between July and 
November 2014. Issues explored included the procurement and storage of medicine, 
overall medicine management and reasons related to expiration of medicines. 
Interviews lasted for approximately 30 minutes per person. All but one participant 
(n=12, 92%) were female and the average length of service among participants 
working at the hospital was 7 years (SD: 6.50). Five (38%) participants were qualified 
pharmacists, two (40%) of whom had previously worked in the private sector for more 
than ten years. Participants were drawn from the pharmacy, as well as other relevant 
wards and units, such as the emergency unit, outpatient departments, theatre, surgical 
and medical units (as shown in Table 5). This is because medicine management is not 
restricted to pharmacists and is also managed by nurses and pharmacy assistants as 
shown in Table 5: 
Table 5: Descriptive statistics of participants (N=13) 
Variable n (%) 
Female 12 (92) 
Qualifications of participants 
 Bachelor of Pharmacy (BPharm) 
 Professional nurses 
 Enrolled nurses 
 Pharmacist assistant - intern 
 Qualified post basic assistant 
 
5 (38.5) 
3 (23.1) 
2 (15.4) 
1 (7.6) 
2 (15.4) 
Mean years in private sector (SD) 3 (4.37) 
Mean years at facility (SD) 7 (6.50) 
Mean years managing a unit at hospital 
(SD) 
1.5 (2.38) 
SD: standard deviation; n: sample 
Two main themes emerged; i) Knowledge, understanding and practical application of 
policies and procedures related to expired medicines, and ii) Diversion from Ideal: 
procedures and constraints which may impact implementation. 
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There were a number of different practices in the different units which resulted in the 
diversion from the ideal management of expired medicines (policy and procedures) 
and the practiced pathways (actual implementation). It is in the diversions between the 
two that key gaps, constraints and challenges to managing expired medicines emerge.  
Theme 1: Knowledge, Understanding and Practical Application of 
Policies and Procedures Related to Expired Medicine 
 
Ordering of medicine 
According to the Gauteng Provincial Pharmaceutical and Therapeutics Committee 
(PTC) guidelines, a committee should be in place at every institution for the selection 
and promotion of rational medicine use (Gauteng Province, 2013). It is recommended 
that re-order levels are reviewed bi-annually to minimise overstock of items which may 
result in medicines expiring. This will further enhance the quantification of needs 
whereby minimum inventory levels are maintained. In the study site, there is a 
Standard Operating Procedure (SOP) on the ordering, storage and packing of 
medicine that was developed by the Gauteng Pharmaceutical Services Directorate to 
be used in facilities in the province (Appendix H). Three participants reported an 
awareness of a detailed SOP’ (Participant #4). All participants noted that, when 
ordering was necessary, a uniform ordering process was always followed amongst all 
departments ‘Main stores - Monday weekly order’, ‘We place our order every Monday’, 
‘Order prepared on Sunday and sent to pharmacy on Monday’ (Participants 1, 5 and 
12).  
Pieced together from different points of view, as described by different participants 
depending on their location in the hospital, the ideal ordering procedure can be 
summarised as follows: It is dependent on where the medicines are ordered from. 
Similarly, the lead time for receiving medicines is also dependent on who the supplier 
is. All medicines ordered from the depot have a lead time of one week, all direct 
delivery vouchers (DDV) medicines are received within 21 days and non-essential 
medicine that are not on contract have a lead time of approximately three (3) months. 
Most of the medicines (80%) are ordered from the depot and all departments, including 
those in the pharmacy placed weekly orders. Provision is made for emergency items 
if weekly order submission to the depot is not submitted on time; however it is restricted 
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to five items as explained;  ‘Urgent orders cannot be more than 5 items or big 
quantities’ (Participant #6). 
The system used by main stores to order stock from the depot is computer-based, 
however all other departments at the hospital use a paper-based system. Though 
minimum and maximum medicine levels are part of the SOP, this practice is not fully 
adhered to. Participants emphasized the importance of ordering medicine timeously, 
however observations revealed that certain medicines exceeded their maximum levels 
as most departments ordered without considering current stock on hand. All 
participants explained that they feared stock outs and preferred hoarding stock:  
‘Stock outs are our biggest challenge - when medication is out of stock we have 
to borrow, which is difficult’ (Participant #5).  
 
This practice resulted in irregular ordering which on the one hand may be seen as the 
disruption of average monthly consumption, while on the other as a proactive measure 
for accommodating long holidays which may interrupt supply or an effort to anticipate 
future failings in the system. 
 
Storage of Medicines 
According to the hospital’s SOP, the pharmaceutical storage area must be under the 
control of the responsible pharmacist and delivery of medicines must be made directly 
to the pharmacy. The responsible pharmacist is not present at all departments all the 
times, hence different staff are assigned for unpacking and storage of medicines. Who 
these staff members are and how medicines are received and stored is mainly 
dependent on the department. The SOP also encourages someone to always be 
present to receive medicines and ensure the packing and storing thereof. At this 
facility, a ‘Ward Medicine Champion’ and pharmacist’s assistant is elected to fulfill this 
role. Observations showed that in some cases the person responsible for packing the 
stock did not verify the number of items received in relation to the orders placed. 
Additionally, in some instances the same items were ordered again with the next order 
placed by the ward.  
Implementation of First Expiry First Out (FEFO) 
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The participants shared similar perspectives regarding the explanation of FEFO and 
its implementation. Whilst the majority of the participants claimed that they knew what 
the acronym means, almost half explained FEFO according to principles of First in 
First out (FIFO). FEFO is a stock rotation method to ensure that medicines with the 
earliest expiry date are used first, whereas FIFO focuses on using stock that was 
received first regardless of expiry date. The implication for confusing the two terms 
(FEFO vs. FIFO) may result in medicines expiring. Although respondents were aware 
of the acronym, their knowledge itself was incorrect. Although the end result may be 
the same. Sometimes, medicines that were received first may expire first, and may be 
used before expiry. This may be different from respondents accurately knowing what 
to do but not being able to practice this due to constraints or practical issues. 
All participants knew who was responsible for monitoring FEFO in their respective 
units but not all responsible employees understood or were held accountable for 
ensuring adequate implementation of FEFO. For example, all departments assigned 
a specific person responsible for monitoring the practice. However there was no 
training provided or criteria set for an individual to be considered competent. Below 
are examples of the various perceptions of participants regarding monitoring of the 
FEFO process; 
 ‘The pharmacist in charge of the department is responsible for monitoring 
FEFO’ (Participant #8);  
‘The sister in charge is responsible of medication (ward champion) for 
monitoring the practice’ (Participant #10). 
‘Yes, I (ward champion) am in charge of monitoring FEFO but no one checks if 
I do it correct’ (Participant #9). 
The hospital SOP encourages the use of colour coded stickers as a guide to actively 
practice FEFO. The colour coded sticker provides an estimated timeframe in which 
certain medicines will expire. This practice was observed in all inpatient wards and 
outpatient clinics visited. This directly made every person in that unit equally 
responsible for monitoring medicine expiration dates because each colour coded 
sticker has a specific expiry date meaning. However, no one can be held individually 
accountable even if this practice is not adhered to. ‘Colour coded stickers are used to 
mark drugs and it is then packed accordingly. Drug ward champions were chosen at 
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each ward and they decided on the colours’ (Participant #13). ‘FEFO is important to 
avoid stock from expiring and everyone in the unit should be responsible’ (Participant 
#3). 
Significance of FEFO Process and Policy 
According to the SOP, the document should be shared with and signed off by all 
employees. All participants were aware of the SOP related to practising FEFO, 
however the SOP was not shared with or signed by all employees ‘There is an SOP 
but only certain departments share the SOP with employees’ (Participant #4). 
Therefore, employees in these departments cannot be held accountable for not 
adhering to the SOP. In addition all participants found the practice of FEFO important 
though the implementation thereof was also explained to be difficult to monitor in 
certain instances. 
‘In the bulk/main stores, stock is packed in batches and this is linked to expiry 
and pharmacist pick according to batch therefore easy to ensure FEFO is 
practiced. Sometimes it is not practiced in the pharmacy in-patient department 
because it is not easy to monitor as drugs are open and not packed by batch’ 
(Participant #1).  
Along with knowledge pertaining to the policy, the value and significance of monitoring 
FEFO was highlighted by all participants to;  
 reduce expired stock: ‘FEFO is important because it reduces the risk of 
expired stock (Participant #1); minimize financial loss: ‘It is important 
because drugs are very expensive and costly to write off one drug. If it 
is expiring soon, we make a plan - to move it out or double up small 
strength to get bigger strength’ (Participant #8);  
 avoid stock outs due to long ordering lead times: ‘It is important because 
of different ordering processes and long lead times, some items can be 
slow movers and FEFO helps organize stock correctly’ (Participant #4) 
and;  
 help identify short dated items:  ‘It is important because of different 
ordering processes and long lead times, some items can be slow movers 
and FEFO helps organise stock correctly’ (Participant #5). 
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Medicine Management Training 
Medicine management training is an important component to enhance stock 
management. This training emphasises the principles and implications of use, 
selection, distribution and overall effective management of medicine. Medicine is not 
only managed by the pharmacist, but includes pharmacy assistants and nurses. Thus, 
there is need to ensure everyone who manages medicine should undertake medicine 
management training. Only two participants were confident in reporting that they 
received medicine management training and are actively implementing it. ‘Yes, I have 
[had] drug management training and it included - supply chain and stock management 
and financial management training’ (Participant #4). 
The remainder of participants reported that they never received medicine 
management training or had only learnt theory during a module at university or college. 
All participants acknowledged that training on medicine management is important, 
however the coordination of such training can be challenging. Participants advised 
that in-house refreshers should be arranged by the pharmacy department, although a 
number of reasons were given for the lack of in-house training, including difficulties in 
finding suitable times: ‘…and there is need for in-house refreshers, however it is not 
easy to organise due to time constraints and staffing’ (Participant #1); ‘…there is need 
for in-house refreshers, especially when new staff starts at the beginning of the year’, 
but this is not conducted due to time constraints (Participant #2); staff rotations: ‘…this 
is done but there are many rotations which interrupt the trained staff’ (Participant #4); 
and lack of prioritization:  ‘…In-house refreshers are important, however it is not done 
because of low priority associated with drug management’ (Participant #8). 
Process of Medicine Management 
According to the SOP, there is need to conduct periodic stock takes and monthly stock 
counts. All participants reported that stock take procedures are conducted as a method 
to manage their medicines. However different departments follow different processes 
and have different timeframes for conducting stock assessments, which is decided by 
the department manager. daily, ‘…every day, stock balance is done for scheduled 
drugs’ (Participant #8), weekly, and ‘…mini stock taking done on Fridays’ (Participant 
#5). In others, it occurs bi-annually, ‘…We have stock taking twice a year (March and 
September) and this timeframe was chosen by Province’ (Participant #1), or even on 
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an irregular basis, ‘…Stocktaking is done on allocated days, before ordering. 
Stocktaking done also after receiving stock’ (Participant #13). 
During observations, it was evident that all departments conduct some form of stock 
take based on the data that was captured. However, the aim and reason for these 
stock takes were unclear among the participants. Additionally, there was a lack of 
knowledge on how and why a stock take should be conducted. For most, it was seen 
as merely a packing exercise across all departments, without any specific guideline or 
format. 
Theme 2: Diversion from Ideal: procedures and constraints which 
may impact implementation 
 
The in-depth interviews suggest that there is knowledge (although not always 
accurate) of how medicines should be managed. However practices often divert from 
the ideal. A closer examination to explore the reasons for these diversions - the ‘whys’- 
revealed three thematic areas: 
 mistrust among employees and in the system,  
 fear of being ‘caught’ yet lack of accountability 
 ineffective communication and coordination 
 
1. Mistrust Among Employees and in the System 
 
Ineffective Inventory Management 
When exploring the possible reasons why medicines expire, participants mainly 
attributed it to ineffective inventory management.  Ineffective management can be 
curtailed by identifying internal and external contributing factors that can be used to 
strengthen intervention. There are aspects within pharmacist control to minimise 
medicines expiry and these are average consumption, quantity on hand and re-order 
levels as highlighted in the following extract: ‘Sometimes medication is on medication 
trolley or in the cupboard that is not counted as stock and an order is placed for this 
drug’ (Participant #9).  
There are also aspects out of the control of pharmacists which include storage 
capacity, procurement period, lead time and minimum order quantity prescribed by 
policy for example the National Core Standards medicines checklist; as mentioned 
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‘Long lead times make me feel pressure to order more than what I need - service level 
agreement needs to be re-examined’ (Participant #5). Additionally stock is ordered in 
excess regardless of the minimum and maximum ordering system and re-ordering of 
available medicines. Participants’ orders may be influenced by past experience of 
either receiving lower quantities or delayed deliveries. It may also become more 
challenging to borrow medicine from neighboring facilities due to similar system 
related challenges may be experienced. 
Though reasons to minimize overstocking and increase effective management of stock 
are relevant, there are certain instances that cannot be avoided which further 
perpetuate this challenge. Over the Easter and Christmas long holidays, the depot 
have less employees for periods of up to 10 working days which may interrupt the 
continuous supply of stock. One participant mentioned that ‘Holidays interrupt ordering 
and receiving stock, therefore order excess ahead of time to cater for the holidays’ 
(Participant #1). 
Ineffective/Conflicting Relationships between Stockpiling & Tender 
Processes 
Most participants anticipated the late renewal of tenders and attributed much of the 
expiration of medicines to this process. Participants mentioned that there is usually a 
delay in the contract end date of the current supplier and start date of new supplier 
especially if they are not the same. This therefore resulted in stock hoarding as well 
as receipt of short dated stock as indicated in the following extracts, ‘If the tender is 
not functional, the company can supply short dated or expired stock - however, short 
dated items that are not fast moving, are sent back’ (Participant #1), another 
participant highlighted that ‘…pressure to receive short dated stock due to short supply 
from the pharmacy/depot and unable to dispense this drug before expiry’ (Participant 
#5). 
In addition certain participants mentioned the need for stockpiling, regardless of the 
implications for transparency and accountability: ‘…there is pressure to keep buffer 
stock for situations when there is no stock’ (Participant #5) and ‘…non-payment of 
suppliers, put pressure to order excess so there is always stock’ (Participant #1). 
Another participant explained that the public sector is a dumping ground for short 
dated items, ‘Public sector is seen as a dumping ground and are given short dated 
stock. Short dated stock expires within one year’ (Participant #4). 
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Rotation of Prescribers 
Participants highlighted human resources rotation as an important aspect that impacts 
on the expiry of medicines. Participants mentioned that doctors are rotated frequently 
among different hospitals and also between public and private sector resulting in 
‘overstocking - stock is ordered according to doctor and when the doctor is rotated, 
the stock will sit’ (Participant #4). Additionally, the high rates of absenteeism at the 
facility further influences efforts to minimise wastage in the form of medicine expiration:   
‘We never have the full staff complement in the pharmacy because there is 
someone absent for one or other reason on a daily basis. Staffing - are unable 
to perform the functions that should be happening’ (Participant #4).  
 
Change in Formulary of Standard Treatment Guidelines 
Whenever a change in standard treatment guidelines occurs, usually every two years, 
stock may not be recommended as per the treatment guideline, however not enough 
time is given between policy change and implementation. In addition, such changes 
are not communicated in a timeous manner to other healthcare workers in the facility, 
and therefore increasing the risk of medicines expiring as explained: 
‘Pharmacy need to communicate if there is a change in drug name or replacement, 
send out a memo’ (Participant #13). 
 
2. Fear of Being ‘Caught’ yet Lack of Accountability 
 
Staff Practices  
Participants’ felts that consequences of irregular practices such as hiding excess stock 
were not clearly communicated to staff. With this, they suggested that employees are 
not held accountable for such practices as explained by Participant #4 ‘Departments 
are hiding away excess stock.’ During observations the researcher noticed a box of 
expired medicines that had been actively hidden in a cupboard for fear of it being found 
by the pharmacy department during the monthly audit. There are no guidelines or 
procedures to follow when an employee is caught hiding some medicines. And this 
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observation was confirmed by one participant who indicated the following; ‘If a drug 
has been removed from the shelf by staff and has not been dispensed to a patient, 
staff can forget to return it in a timely manner before it expires’ (Participant #12). 
 
3. Ineffective Communication and Coordination 
 
Ineffective Communication 
For many in the study, the efficient and effective management of medicine is a 
challenge due to the lack of communication among different departments. The 
pharmacy department plays a pivotal role in facilitating communication to provide 
updates on items that have a slow turnover as well as address knowledge gaps 
identified.  However, this communication is not disseminated timeously and may cause 
confusion among prescribers. Ineffective communication further forces employees to 
order higher quantities. Furthermore, the pharmacy department should be held 
accountable when communication is not effective. Participants had similar views when 
discussing the level of communication among departments which may directly impact 
on medicines expiring, and their views are indicated by the extracts;  
‘Lack of communication of available stock to doctors. The supplier will 
communicate to the pharmacist about unavailable drugs and suggest an 
alternative, but it is not communicated. When the drug becomes available, drug 
prescription is not changed’ (Participant #7).  
Infrastructural System Issues 
Participants mentioned that the use of a manual system makes it difficult to trace stock, 
for instance one participant mentioned that, ‘Manual system makes it hard to track 
stock once it is released to OPD or the wards’ (Participant #1). Additionally, ‘Majority 
of stock are kept at ward levels and there is no control over their stock due to manual 
system still practiced’.  
An electronic system called Rx Solution® was recently installed at the hospital. Rx 
Solution® is a pharmaceutical management system that has various capabilities, of 
which one includes the ability to minimise the number of expired medicines. However, 
the roll-out of the system has been limited by lack of necessary equipment in the 
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hospital as indicated; ‘Rx Solution® is meant for stock management, however there 
are no computers’ (Participant #4).  
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CHAPTER 5: DISCUSSION  
 
 
The aim of this study was to describe the economic impact related to, and reasons for, 
the expiry of medicines at a large urban hospital in Johannesburg, South Africa from 
January 2011 until June 2014. The total estimated value of financial losses due to 
medicine expiry was R836 029; an estimated annual revenue loss of 0.6% of the total 
hospital expenditure. This percentage is lower than the allowed percentage in Gauteng 
Province of 1% (Pharmacist, 2012). However, a 0.6% loss in revenue due to expired 
medicines presents an opportunity cost as the funds could have been directed to meet 
other healthcare needs in light of the budgetary constraints that the health system 
faces. In addition, an average increase in revenue loss of 72% is significant given that 
budgets are shrinking annually, as is the case at this urban hospital. The annual 
budget increase for provincial pharmaceutical services is horizontal and the average 
increase is approximately 16% which is almost five times lower than the average 
annual increase in revenue lost due to expired medicine (Pharmacist, 2012) 
 
According to this study more than 80% of the medicines that expired were on the 
essential medicine list (EML), with antibacterial for systemic use (16%, n=5067) and 
antivirals for systemic use (15%, n=4970) among the highest classes that expired. To 
explain ‘why’, two main themes emerged, focusing on the ideal management, 
understanding (policies and procedures) and the practiced pathways (actual 
implementation). Furthermore, this study found that all the top medicines that expired 
at this hospital either have high consumption rates or are vital where non-adherence 
may be fatal.  Chronic diseases require long-term compliance to treatment and the 
expiry of medicines such as anti-diabetics may force patients to either buy or forego 
treatment. A possible reason for expiry of expensive medicines may be that such 
expired medicine is only used for emergency cases such as Streptokinase in Cardiac 
Failure which should be administered within one hour of the event (to a maximum of 
12 hours). The consumption at this tertiary hospital may be low and it is possible that 
patients consulted elsewhere before arriving at this hospital, thus the time window for 
use of Streptokinase may have passed. 
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Availability of essential medicines is needed for healthcare delivery and, consistent 
with other studies, these findings confirmed that expiry of medicines was highest 
among essential medicine (Nakyanzi et al., 2010). The lack of access to essential 
medicines due to wastage may cause households to face financial catastrophe by 
paying out of pocket for medicine in the private sector (McIntyre et al., 2006), making 
medicine the largest household expenditure item after food (Prinja et al., 2015). 
Additionally, lack of essential medicines may result in low staff morale and reduce 
confidence in the health system by patients and healthcare workers (Penfold et al., 
2013), which may impact accountability. 
Governance and Accountability 
In South Africa, there are various documents such as Good Pharmacy Practice (GPP) 
and the Public Financial Management Act (PFMA), which may assist in the guidance 
and management of medicines. At facility-level, detailed SOPs provide additional 
direction and control to ensure delivery of services. The challenge however remains 
that although a document is developed, its implementation and success is dependent 
on the custodians of such documents. In this study, the custodians of the policy are all 
stakeholders who manage medicines, such as pharmacists, pharmacy assistants and 
nurses, though the pharmacist is responsible for the overall management of medicines 
at facility level. The scope of practice which determines the activities, responsibilities 
and accountability of pharmacy assistants practice setting have been developed by 
the South African Pharmacy Council (Council, 2011). However, pharmacy assistants 
require in-service training in effectively completing organisational level tasks related 
to calculating re-order levels, rational procurement and, monitoring and evaluating 
medicine use. In our study, the need for in-service training was highlighted as 
important, however suitable times for such training was challenging given the daily 
turn-over of patients .   
Expiry of medicine is serious, as underscored by all guiding documents that seek to 
minimize the practice. There are additional constraints when the relationship between 
these documents and daily practices are not understood and accountability is not 
assigned, key findings of this study.  These findings resonate with similar challenges 
faced by local governments without powers to address important public health 
determinants or hold implementers accountable see for example, (Livingston et al., 
2007, Maclennan et al., 2013). Furthermore, while the hospital PTC may provide 
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guidance in ensuring accountability, the PTC often does not have powers to enforce 
accountability (as in this study and elsewhere).  
 
 
Policy Change 
 
The South African National Core Standards policy was developed by the Office of 
Health Standards Compliance with the aim of monitoring services using set criteria to 
benchmark quality of care provided at public healthcare facilities (National Department 
of Health, 2011). The National Core Standards consist of seven domains and 
pharmaceutical services is one of the categories in the Clinical Services domain 
(National Department of Health, 2011). Facilities are audited against the set criteria on 
a regular basis, which include a list of medicines that should be available in the 
specified dosage form and pack size. However, the list does not consider the 
consumption of an item at a specific institution. In this study, pharmacy managers felt 
forced to ensure that these medicines, (for example: Lamivudine Tablets 150mg; 60`s) 
are always available in the required quantity, thus increasing the risk of expiry. 
Furthermore, a key finding is that the medicines expiring with low consumption may 
be as a result of the minimum quantity set by the National Core Standards criteria that 
may be too high for this urban tertiary hospital. In addition, at organisational level, the 
lack of coordination with regards to demand planning and quantification may also be 
contributing to medicines expiring.  
 
This study, similar to Jha and Roy (2005) found that though adequate tools for 
quantification and demand planning exist, none of it is focused on the health worker 
who has no formal training in medicine supply management. On the one hand, even 
with robust training and adequate investment in skills development related to medicine 
management, job descriptions may not be aligned with the responsibility of medicine 
management. Job descriptions do not assign individuals responsibility for managing 
medicines (beyond the roles of pharmacists) means that there may also be a gap in 
accountability because individuals are –de facto - “responsible” but without any formal 
sense of duty. Additionally, without active monitoring at organisational level, the impact 
may be minimal. 
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Change in Treatment Policy 
There is robust evidence that changing therapies is a significant cause of medicine 
wastage (WHWorld Health Organisation, 2010). In 2012 Dr Aaron Motsoaledi, South 
Africa’s Minister of Health, announced the award of a new ARV tender – worth 
approximately R6 billion – that included, for the first time since the start of the ARV 
programme, the FDC tablet (Clinicians Society of SA HIV, 2013). NDoH provided 
recommendations on patient priority groups to receive FDC, however at 
implementation level these priority groups were not optimally adhered too (Clinicians 
Society of SA HIV, 2013). In this study, this change in treatment policy may be 
associated to the expiry of ARVs at this urban tertiary hospital. This finding may 
suggest a lapse of coordination at the organisational level in ensuring the depletion of 
triple therapy prior to dispensing FDC to patients. Medicine waste may be curtailed by 
improved management and coordination at the organisational level during 
procurement phase, thereby only procuring what is needed. However, at a national 
level, this may require a flexible policy environment that allows for the phasing in and 
out of new medicines in ways that ease organizational processes. 
 
Limited Knowledge of Standard Treatment Guidelines (STGs) 
 
In this research, more than half of the antibacterials for systemic use that expired were 
first line therapy for various infections as per the STGs. This finding  supports  the 
recent WHO finding that fewer than 40% of patients are treated according to STGs 
(WHWorld Health Organisation, 2010). This may be due to a lack of STG knowledge 
among prescribers. In South Africa, prescribers rotate quarterly among facilities within 
a district with the aim to ensure consistent services are provided and expose 
prescribers to different all levels of care. Due to the shortage of healthcare workers in 
Africa (Naicker et al., 2009) and specifically in South Africa (Rispel and Blaauw, 2015), 
certain prescribers work in both the public and private sectors which may further 
influence prescribing patterns. External prescribing influence, that is practices beyond 
the public health system, highlights the need to carefully monitor health system 
performance at organisational level to prevent poor health outcomes (Rispel and 
Blaauw, 2015). The quantity of medicines dispensed may therefore not be a true 
reflection of the demand due to irrational prescribing that may be influenced by these 
underlying contributing factors. 
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Medicines are dispensed based on what is prescribed by the doctor. Dispensing data 
is used to assist pharmacy managers with future planning that may directly impact 
estimates provided for the tender processes and the allocated budget that this urban 
tertiary hospital may receive. When medicines are irrationally prescribed and 
irrationally dispensed, it may lead inaccurate information generated which may either 
be lower or higher than anticipated, thus increasing the risk of medicine expiry. 
Medicine expiry may be averted with improved knowledge of STGs among prescribers 
and accurate data management.  
 
Electronic Inventory Management System 
 
Infrastructure remains a contributing factor to challenges in healthcare systems 
globally (Hawkes et al., 1994). Some progress has been made at this urban tertiary 
hospital to support pharmacy product distribution by an electronic stock management 
system, Rx Solution®, which manages the dispensing of medicines and automates 
ordering. The system provides significant information to assist managers in making 
appropriate decisions, such as averting financial loss due to expired medicines and 
effectively manage inventory. Despite the numerous tools that are available both on 
Rx Solution® and in each unit, the task of managing medicines in all units, except 
pharmacy, is dependent on the nursing staff who are already overburdened (Jha and 
Roy, 2005) and the lack of computers. The use of a computerised inventory 
management system may improve the operational efficiency but additional challenges 
may emanate, related to the ability of operating an electronic system. Adequate 
training is important in ensuring the use of the electronic system. 
This study provides critical insight as a step in identifying ways to improve operational 
efficiency and cost effectiveness in a large urban tertiary public hospital, particularly 
through the lens of medicine management. In South Africa, the government 
contributes approximately 40% of all expenditure on health and therefore a yearly 
increase of 72% in medicine expiring is alarming given that all other wastage forms 
such theft, pilferage or medicine returns are not included in this figure. This percentage 
may therefore be even higher if all other forms of wastage are included. This study 
also highlights that medicines expiring may be curtailed with improved management 
at the organisational level. Many reasons for medicines expiring in this study are within 
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the control of the hospital and thus there is an opportunity to implement appropriate 
interventions and efforts to improve inventory and financial inefficiencies.  
 
LIMITATIONS OF THE STUDY 
 
The study was only conducted in one urban hospital and the results are therefore not 
statistically generalizable to other similar level hospitals or primary healthcare (PHC) 
clinics. However, theoretical generalisation is possible through the themes of 
kknowledge, understanding and practical application of policies and procedures 
related to expired medicines, and diversion from Ideal: procedures and constraints 
which may impact implementation. The quality of the quantitative data also imposed a 
limitation as the expired medicines (between 2011 to mid-2014) were collected for a 
different purpose and the data were not validated during the hospital audit (carried out 
in 2010). Furthermore, these data were only captured once by the person who 
collected the information and there were no quality checks performed on the data to 
ensure accuracy. The dataset comprised medicines with different formulations making 
it more challenging to determine the true extent of quantity lost due to expired 
medicines. The actual date of expiry of medicines that were pre-packed at the facility 
into smaller unit packs could not be quantified, yet it is important to acknowledge that 
medicines that have already been opened have a reduced expiry date (Pharmacist, 
2012).  
No analysis was carried out on the extent of expired medicines at patients’ homes 
(that is, ‘downstream’ of the organisational-level of medicine supply).  There is 
evidence that both patients and doctors experience medicine expiration in their homes 
(Nguyen et al, 2002). The budget or expenditure were not made available in certain 
articles referenced which limited the any reference related percentage loss between 
different articles. In addition, other forms of medicine wastage such as patient returns 
of non-expired medicines were not analysed. Apart from the actual value of the 
medicines that expired, additional costs are incurred including costs of collecting and 
transporting medicines to the accredited disposal area. Such costs were not estimated 
in this study. The participants were interviewed in one point in time and may have 
changed positions over time, or might not have had full knowledge of medicine expiry 
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factors at that point. This is a high volume hospital and staff members were very busy. 
Thus they may not have provided as much information as they had during the interview 
as this may have delayed operational activities.  
Though analysing the medicine expiring in the pharmacy department is useful, the 
study looked at the hospital instead of different departments and focused on the types 
of medicine instead of the different departments. This is certainly an area for future 
work as such analyses may highlight additional nuances and differences between 
trained pharmaceutical staff and other staff within the hospital. Additionally, more 
specific recommendations for different wards may provide more strategic guidelines 
and procedures for the future. 
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RECOMMENDATIONS AND CONCLUSION 
 
The key finding of this study is that medicine expiry may be curtailed by enhanced 
management strategies. Most of these strategies can be adopted and improved at the 
organisational level, where the biggest impact may be made. The recommendations 
acknowledged for this study include: 
 Continuous monitoring and periodic evaluations to identify and address 
challenges related to medicine management to reduce medicine wastage; 
 Active control over financial resources given that wastage may be enormous 
and limit availability of medicine; 
 Create awareness about the risk of medicines expiring and cost impact on 
service delivery; 
 Enhance distribution mechanisms from suppliers that support the early use 
of medicines at risk of expiring by the hospital; 
 Develop capacity and enhance skills among health workers who manage 
medicine, to optimally use tools that are aimed at reducing wastage of 
medicine; 
 Improve communication from pharmacy to other units on any changes to 
STGs and availability of vital medicines; 
 Identify innovative ways to ensure the use of STGs;  
 Conduct departmental specific expiry reports to provide more strategic 
guideline to reduce waste. 
 Pharmacy management should be aware of medicines with slow or 
unpredictable turnover at the facility that are most likely to expire; 
 Use technology as a tool to improve coordination and provide harmonized 
procurement and prevent overstocking which may lead to medicine 
wastage; 
 Proactively develop an implementation plan when policy changes or tender 
changes are announced that may impact medicine expiry; and 
 Include MSM as part of job descriptions on employees who manage 
medicines at this hospital to enhance accountability. 
 Consider employing clinical pharmacists at tertiary hospitals to improve 
medicine management in the wards. 
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CONCLUSION 
This study shows that the majority of medicines that expire at the tertiary hospital are 
on the EML. Medicine use is only possible if there is access, therefore minimising 
waste may contribute to access and availability. Sound coordination and 
communication is needed between the pharmacy and other departments in the 
hospital. Additionally, Pharmaceutical and Therapeutics Committees should 
emphasise the use of STGs. Medicine management is not restricted to the role of the 
pharmacist and, though the tools that exist support individual performance, the 
application of these tools require personal skills. Rigorous vigilance in medicine 
management and maintenance of demand planning at hospital level may improve 
stock management. Accountability can only be effective if it is assigned and practiced. 
In South Africa, pharmacists are responsible for medicine management, however were 
confined to the pharmacy in this study and medicine management was extended to 
nurses. The employment of clinical pharmacists in the wards at this tertiary hospital 
may improve medicine management in the wards.  
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APPENDIX A 
Data Extraction Tool 
Drug 
Name 
Drug 
Code 
Class 
of 
drug 
Drug 
strength 
Date 
manufactured 
or Batch 
number 
Date 
procured 
Date 
expired 
Date of 
drug 
expiration 
recorded 
Unit  
from 
which 
drug was 
recorded 
Method 
of 
storage 
Unit cost Route of 
administration 
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Appendix B 
Anatomical Therapeutic Chemical Classification 
ATC code ATC description 
A02 ANTACIDS, DRUGS FOR TREATMENT OF PEPTIC ULCER AND FLATULENCE 
A03 ANTISPASMODIC AND ANTICHOLINERGIC AGENTS AND PROPULSIVES 
A04 ANTIEMETICS AND ANTINAUSEANTS 
A06 LAXATIVES 
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS 
A10 DRUGS USED IN DIABETES 
A11 VITAMINS 
A12 MINERAL SUPPLEMENTS 
B01 ANTITHROMBOTIC AGENTS 
B02 ANTIHEMORRHAGICS 
B03 ANTIANEMIC PREPARATIONS 
B05 BLOOD SUBSTITUTES AND PERFUSION SOLUTIONS 
B06 OTHER HEMATOLOGICAL AGENTS 
C01 CARDIAC THERAPY 
C02 ANTIHYPERTENSIVES 
C03 DIURETICS 
C05 VASOPROTECTIVES 
C07 BETA BLOCKING AGENTS 
C08 CALCIUM CHANNEL BLOCKERS 
C09 AGENTS ACTING ON THE RENIN-ANGIOTENSIN SYSTEM 
C10 SERUM LIPID REDUCING AGENTS 
D01 ANTIFUNGALS FOR DERMATOLOGICAL USE 
D02 EMOLLIENTS AND PROTECTIVES 
D04 ANTIPRURITICS, INCL. ANTIHISTAMINES, ANESTHETICS, ETC. 
D06 ANTIBIOTICS AND CHEMOTHERAPEUTICS FOR DERMATOLOGICAL USE 
D07 CORTICOSTEROIDS, DERMATOLOGICAL PREPARATIONS 
D08 ANTISEPTICS AND DISINFECTANTS 
D11 OTHER DERMATOLOGICAL PREPARATIONS 
G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS 
G02 OTHER GYNECOLOGICALS 
G03 
SEX HORMONES AND MODULATORS OF THE GENITAL SYSTEM AND 
CONTRACEPTION 
H01 PITUITARY, HYPOTHALAMIC HORMONES AND ANALOGUES 
H02 CORTICOSTEROIDS FOR SYSTEMIC USE 
H03 THYROID THERAPY 
H04 PANCREATIC HORMONES 
J01 ANTIBACTERIALS FOR SYSTEMIC USE 
J02 ANTIMYCOTICS FOR SYSTEMIC USE 
J04 ANTIMYCOBACTERIALS 
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J05 ANTIVIRALS FOR SYSTEMIC USE 
J05 N/A 
J06 IMMUNE SERA AND IMMUNOGLOBULINS 
J07 VACCINES 
L01 ANTINEOPLASTIC AGENTS 
L02 ENDOCRINE THERAPY 
L04 IMMUNOSUPPRESSIVE AGENTS 
M01 ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS 
M03 MUSCLE RELAXANTS 
M04 ANTIGOUT PREPARATIONS 
M05 DRUGS FOR TREATMENT OF BONE DISEASES 
N01 ANESTHETICS 
N02 ANALGESICS 
N03 ANTIEPILEPTICS 
N04 ANTI-PARKINSON DRUGS 
N05 ANXIOLYTICS 
N06 PSYCHOANALEPTICS 
N07 OTHER NERVOUS SYSTEM DRUGS 
P01 ANTIPROTOZOALS 
P02 ANTHELMINTICS 
R01 NASAL PREPARATIONS 
R02 THROAT PREPARATIONS 
R03 ANTI-ASTHMATICS 
R05 COUGH AND COLD PREPARATIONS 
R06 ANTIHISTAMINES FOR SYSTEMIC USE 
S01 OPHTHALMOLOGICALS 
S02 OTOLOGICALS 
V03 ALL OTHER THERAPEUTIC PRODUCTS 
V04 DIAGNOSTIC AGENTS 
V07 ALL OTHER NON-THERAPEUTIC PRODUCTS 
  
58 
 
APPENDIX C 
CONSENT FORM: IN-DEPTH INTERVIEWS 
 
Title of research project: Trend in revenue loss due to expired drugs at a large urban 
hospital in Johannesburg 
 
The study has been described to me in a language that I understand and I 
freely and voluntarily agree to participate. My questions about the study have 
been answered. I understand that my identity will not be disclosed and that I 
may withdraw from the study without giving a reason at any time and this will 
not negatively affect me in any way. I understand there will be no 
reimbursement for participation.  
At all times the researcher will keep the source of the information confidential 
and refer to me and my words by a number or invented name. The written 
transcripts or notes of the actual interview will only be released to supervisors 
who will assist in the data analysis, the number or invented name will be used 
in these transcripts. 
I understand the procedure described above. My questions have been 
answered to my satisfaction, and I agree to participate in this study. I have 
been given a copy of this form  
If you consent to partake in this study please sign here: 
____________________________________________________________ 
Participant signature 
 
____________________________________________________________ 
Date 
____________________________________________________________ 
Interview’s signature 
 
____________________________________________________________ 
Date 
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APPENDIX C 
 
CONSENT TO TAPE RECORD INTERVIEWS 
 
If you consent to partake in the study could you please tick an option regarding audio 
tape-recording:  
I have read the project information sheet and it has been clearly explained to me and I understand 
that it is up to me whether or not the interview is tape-recorded. The purpose of recording the 
interview is to capture accurately all the information that will be given.  It will not affect in any way 
how the researcher treats me if I do not want the interview to be tape-recorded.  
I understand that if my participation is tape-recorded that the recording will be destroyed after 
compilation and completion of this report. I understand that I can ask the person interviewing me 
to stop tape recording, and to stop the interview altogether, at any time. I understand that the 
information that I give will be treated in the strictest confidence and that my name will not be used 
when the interviews are typed up. 
 
___   Yes, I agree to be audio taped during my participation in this study. 
___   No, I do not agree to be audio taped during my participation in this study. 
 
 
________________________________________________________________ 
Interviewee’s signature 
 
  
________________________________________________________________ 
Interviewer’s signature 
 
Date: _____________________________ 
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APPENDIX D 
INFORMATION SHEET 
 
Study title: Trend in revenue loss due to expired drugs at a large urban hospital in Johannesburg, 
South Africa 
 
Hello,  
My name is Celeste Sauls. I am studying towards a Master’s degree in Public Health at the 
University of the Witwatersrand. The purpose of the study is to describe the trend and, determine 
the extent of revenue loss due to expired drugs, and explore possible reasons for such loss. I am 
inviting you to take part in a research study and would be very grateful if you would agree to 
answer a few questions about drug stock management at the Organizational level.  
 
By gathering this data, I’m hoping to assist the hospital and other stakeholders to find ways to 
reduce expired drugs and improve planning as well as monitoring such information. I believe that 
your ideas and thoughts are important and can contribute to this study. The interview will take 
around 60 minutes to complete during which I will be asking  a few questions and would like you 
to tell me what circumstances are really like, not what they should be.  
 
If you feel that a question is inappropriate or too sensitive, you are free not to answer it.  While 
answering all the questions will be most useful for our study, you can decide not to answer any 
questions if you wish. You can stop the interview at any time or ask for clarity when the questions 
are unclear.   
 
To make the interview easier for me, I will also request if we can tape record the interview.  If you 
do not want the interview to be taped that is your right, and it will not influence the interview or 
the research in any way. If you give us permission to tape the interview we will listen to the tape 
and write down everything that you say but not use your name. We will keep the tapes until the 
full report has been compiled and finalised, after which they will be destroyed. 
 
You will receive no direct benefit from your participation in this study. However, your participation 
may help the researcher and the hospital better understand what is needed to reduce drugs 
expiring. Your participation in this study is completely voluntary. If you agree to take part, you can 
stop at any time if you do not want to carry on being involved. If you refuse to take part or stop at 
any point during the study, you will not be affected in any way and you will not be discriminated 
against.  
 
All the information you choose to give me will be kept confidential. Your name will not be used in 
the research report and no one will be able to link your answers to you. Only my supervisors and 
I will have access to the information which will be kept in a secure place. All efforts will be made 
to keep information confidential.  
If you have any questions about this study, please feel free to contact me on: 
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Celeste Sauls 
School of Public Health 
University of Witwatersrand 
Johannesburg 
Tel no: 083 749 6896 
Email: celestesauls@gmail.com 
 
Similarly you can also contact the Human Research Ethics Committee (Medical) which oversees 
the ethical aspects of this study.  Members of this committee can be contacted through Ms. Anisa 
Keshav on 011 717 1234. 
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Appendix E 
Trend in revenue loss due to expired drugs at a large urban hospital in 
Johannesburg, South Africa 
Date: ___________________ 
Study ID: _________________ 
In-depth Interview (Pharmacists/Pharmacist Assistants/Ward managers) 
INTERVIEW GUIDE 
Questions in bold (with prompts below – ONLY if not raised) 
1. What are your qualifications? 
________________________________________________________________ 
2. How long have you been the ward manager at this place/unit 
________________________________________________________________ 
3. What are your years of experience at this facility? 
________________________________________________________________ 
4. Have you ever worked in the private sector? 
________________________________________________________________ 
a. How many years? 
5. Tell me about how you order and store drugs in this ward? 
_____________________________________________________________ 
Prompt if necessary: 
a. Allocated days? 
b. Allocated times? 
c. Ordering forms or computer based? 
d. Do you have any runners? 
e. If no one is available to receive the stock 
f. Reasons for not ordering on specific day? 
g. Responsible for packing drugs? 
h. Open/locked cabinet? 
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i. Room access controlled/not controlled? 
6. May you please explain what FEFO means to you and your unit? 
_______________________________________________________________ 
Prompt if necessary 
a. Why or why not is it important? 
b. Where did you find out about FEFO? 
c. Who is responsible for actively monitoring this practice? 
d. Is it done? 
e. How often? 
f. Is there a SOP 
 
7. Tell me about any training you may have had regarding drug management? 
________________________________________________________________ 
Prompt if necessary 
a. Training important? 
b. Is there need for in-house refreshers 
 
8. Tell me about how you manage drugs in your department 
________________________________________________________________ 
Prompt if necessary 
a. Stocktaking 
b. What made you choose that timeframe? 
c. Monitoring 
d. Challenges 
 
9. Why do you think drugs expire? 
_______________________________________________________________ 
10. What do you think can be done differently at the hospital, if anything, to limit the 
number of drugs expiring on the shelves? 
________________________________________________________________ 
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Appendix F 
Equation for calculating average rate of change 
 
(∑
𝑅𝑎𝑡𝑒𝑦𝑒𝑎𝑟 𝑖
𝑅𝑎𝑡𝑒𝑦𝑒𝑎𝑟 𝑖−1
𝑛
𝑖=2 − 1) 𝑥100
𝑛 − 1
 
Substitute rate with % revenue loss meaning: 
 
((
 % 𝑙𝑜𝑠𝑠𝑦𝑒𝑎𝑟 2
%𝑙𝑜𝑠𝑠𝑦𝑒𝑎𝑟 1
−1)
 + (
(
 % 𝑙𝑜𝑠𝑠𝑦𝑒𝑎𝑟 3
%𝑙𝑜𝑠𝑠𝑦𝑒𝑎𝑟2
−1)
)+
(
 % 𝑙𝑜𝑠𝑠𝑦𝑒𝑎𝑟 4
%𝑙𝑜𝑠𝑠𝑦𝑒𝑎𝑟 3
−1)
)   
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Appendix G 
Study Approval 
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Appendix H 
 
Standard Operating Procedure on Ordering, Storing and Packing of Medicine 
 
SOPS issued by: Gauteng 
Department of Health: 
Pharmaceutical Services 
 
 
 
SOP 4:  PROCUREMENT OF STOCK. 
Number of pages: 8 
Accountable officers: 
The responsible pharmacist at hospital and district pharmacies will be responsible for implementing 
procedures and control measures for the procurement of stock by the pharmacy. Other responsible 
officers to whom this SOP applies either directly or indirectly includes the: 
Pharmacist, basic and post basic pharmacist assistants. 
Clerks, drivers etc. 
 
For district health services where there are no pharmacists or pharmacist assistants rendering the 
service, then the following substitutions in the SOPS are permissible: 
Responsible pharmacist can be substituted with facility manager. 
Pharmacist can be substituted with authorised nurse or doctor depending on who is delegated the 
responsibility. 
Pharmacy can be substituted with medicine room. 
Policy, references and resource material includes: 
    Pharmacy Act (Act 53 of 1974) and Regulations as amended. 
    Medicine  and  Related  Substances  Act  (Act  101  of  1965),  Regulations  and  Guidelines  as 
amended. 
    Public Finance Management Act (Act 1 of 1999). 
    Good Pharmacy Practice in South Africa, Latest Edition. 
Provisioning Administration Manual (PAS Manual). 
Record of amendments: 
Date first issued: June 2000 (Circular Letter 31 of 2000). 
Date issued after first review: April 2007 (Circular letter 4 of 2007 and amendments). 
Date issued after second review: January 2013. 
Area amended: Whole SOP. 
New SOP issue authorised by: Senior Manager: Pharmaceutical Services: Ms. N. Thipa 
 
 
Objective: 
To ensure that standardised processes with regards to procurement are applied throughout 
the province. 
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Procedure: 
1.  How to calculate the Re-order level (ROL) 
    Determine the average monthly demand (AMD) for a period of six month. 
 
 
     Determine the appropriate re-order factor (ROF) for your institution using the table below: 
 
Order interval Lead times in week Re-order factor Stock holding in weeks 
Once a week 1 0.75 3 
Every 2 weeks 2 1.5 6 
Every 4 weeks 4 3 12 
Every 6 weeks 6 4.5 18 
Every 8 weeks 8 6 36 
 
To calculate the re-order level (ROL) multiply the AMD by the 
ROF The ROL is re-calculated every six months. 
The ROL must be calculated for each item in stock and must be written onto the stock car. 
 
 
 
2.  How to use the reorder level 
    If the stock holding is above the ROL then do not order stock. 
    If the stock holding is equal to the ROL then do not order stock, unless due to higher usage e.g. 
seasonal usage. 
    If the stock holding is less than the ROL then order the ROL quantity for that item. 
 
 
3.  Action to be taken before placing an order 
   Follow up on all outstanding orders from the medical supplies depot (MSD) and from the 
suppliers 
Check the delivery schedule from MSD to determine when stock may be arriving. 
If there are already two backorders for an item, do not place the third order before discussing 
with the pharmacist in charge of the store. This can lead to overstock at the institutions when all 
the backorders arrive. MSD reserves the right not to take back any stock that has been repeatedly 
ordered. 
   Check the stock on hand (take into considerations the stock issued on the computer system but 
not yet picked). 
   Check if the quantity of stock on the shelf matches the quantity of stock on the stock card 
(modified VA11) or computer printout as an in-process check. 
   If the quantity of stock on the shelf does not match the quantity on the stock card (modified 
VA11) or the computer print out, this must be reported to the pharmacist, investigated and 
corrected. 
   All discrepancies must be must be recorded on the stock card (modified VA11) or the computer 
print out while the matter is being investigated. 
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   All findings and corrections made to the stock card (modified VA11) or computer system must be 
countersigned or authorised by the pharmacist in charge of the store. 
 
 
 
 
 
 
 
 
 
SOP 7:  EFFECTIVE STORAGE OF MEDICINE AND STOCK CONTROL 
(INCLUDING FEFO AND FIFO). 
Number of pages: 
3 
Accountable 
officers: 
The responsible pharmacist at hospital and district pharmacies will be responsible for implementing 
procedures   and control measures for the effective storage of medicine and stock control in the 
pharmacy. Other responsible officers to whom this SOP applies either directly or indirectly includes the: 
Pharmacist, basic and post basic pharmacist 
assistants. Clerks, drivers etc. 
 
For district health services where there are no pharmacists or pharmacist assistants rendering 
the service, then the following substitutions in the SOPS are permissible: 
Responsible pharmacist can be substituted with facility manager. 
Pharmacist can be substituted with authorised nurse or doctor depending on who is delegated 
the responsibility. 
Pharmacy can be substituted with medicine room. 
Policy, references and resource material includes: 
    Pharmacy Act (Act 53 of 1974) and Regulations as amended. 
    Medicine and Related Substances Act (Act 101 of 1965), Regulations and Guidelines as 
amended.     Public Finance Management Act (Act 1 of 1999). 
    Good Pharmacy Practice in South Africa, Latest Edition. 
Provisioning Administration Manual (PAS Manual). 
Record of 
amendments: 
Date first issued: June 2000 (Circular Letter 31 of 2000). 
Date issued after first review: April 2007 (Circular letter 4 of 2007 and 
amendments). Date issued after second review: January 2013. 
Area amended: Whole 
SOP. 
New SOP issue authorised by: Senior Manager: Pharmaceutical Services: Ms. N. Thipa 
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Objective: 
To effectively store stock and rotate stock by observance of the FEFO and FIFO principles. 
 
Procedure: 
1. All storage areas must be large enough to allow for the orderly arrangement of stock and proper 
stock rotation. It must allow for safe and efficient workflow and effective communication and 
supervision of pharmacist assistants. 
 
2. All bulk stores must be self-contained, secure, and lockable with access limited only to authorised 
personnel. 
 
3. Storage  areas  must  have  sufficient  shelving  constructed  from  a  smooth,  washable  and 
impermeable material which is easy to clean and maintain and suitable to keep medicine above floor 
level. 
 
4. There  must  be  appropriate  storage  facilities  for  thermo-labile  items,  see  SOP:  Cold  chain 
management. 
 
5. There must be appropriate storage facilities for hazardous substances. 
 
6. Appropriate storage facilities for the SS5 and S6 medication must also be available, See SOP: 
Management of Schedule 5 and schedule 6 medication. 
 
7. All medication must be stored systematically according to dosage forms and in alphabetical order 
by generic name. 
 
8. The system should allow for ease of counting and identification of the items. 
 
 
9. Shelves must be labelled with the items generic name. 
 
 
10. There should be a physical separation or space between each item. 
 
 
11. Stock must be stored on the shelves or pallets and not directly on the floor. 
 
 
12. All stock must be packed away using the FEFO (where there is an expiry date) and FIFO (where 
there is no expiry date) principles. 
All new stock received into the store must be checked for an expiry date. 
Stock nearing expiry should not be received unless it can be used before the expiry date. Short 
expiry dates must be reported to the pharmacist for a decision. 
   All medicines with an expiry date must be arranged in such a way that the short dated stock is 
stored in front and used first. The order in which these medicines are received into the store is 
not of importance. 
   A system to easily identify short dated stock must be implemented e.g. a colour coding system, 
to minimise losses. 
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   All medicine without an expiry date must be arranged in such a way that the stock that received 
first is always in front and used first. 
   The system of packing stock should allow for ease of counting and identification of items. 
 
 
13. There must be a stock card (modified VA11) for each medicine in the store, including ARV’s. The 
following must be recorded on the stock card (modified VA11) for all new stock received: 
Date; 
Document number; 
Quantity received; 
New balance; 
Signature; 
Expiry date; 
Batch number (to facilitate batch recall); 
Other relevant information such as batch number, orders placed, expired stock removed etc.10. 
At least monthly stock counts, expiry date checks and checking for obsolete and unusable 
stock must be conducted within the bulk store and the satellite pharmacies, wards, consulting 
rooms etc. and must be handled in accordance to the SOP: Checking for obsolete, expired and 
unusable stock 
 
11. An audit trail of all stock received, issued, removed must be maintained on the stock card 
(modified VA11). 
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SOP 9:  CHECKING FOR OBSOLETE, EXPIRED AND 
UNUSABLE STOCK. 
Number of pages: 4 
Accountable officers: 
The responsible pharmacist at hospital and district pharmacies will be responsible for implementing 
procedures and control measures for the checking of obsolete, expired and unusable stock in all areas 
where  medicine  is  kept.  Other  responsible  officers  to  whom  this  SOP  applies  either  directly or 
indirectly includes the: 
Pharmacist, basic and post basic pharmacist assistants. 
Clerks, drivers etc. 
 
For district health services where there are no pharmacists or pharmacist assistants rendering the 
service, then the following substitutions in the SOPS are permissible: 
Responsible pharmacist can be substituted with facility manager. 
Pharmacist can be substituted with authorised nurse or doctor depending on who is delegated the 
responsibility. 
Pharmacy can be substituted with medicine room. 
Policy, references and resource material includes: 
    Pharmacy Act (Act 53 of 1974) and Regulations as amended. 
    Medicine  and  Related  Substances  Act  (Act  101  of  1965),  Regulations  and  Guidelines  as 
amended. 
    Public Finance Management Act (Act 1 of 1999). 
    Good Pharmacy Practice in South Africa, Latest Edition. 
Provisioning Administration Manual (PAS Manual). 
Record of amendments: 
Date first issued: June 2000 (Circular Letter 31 of 2000). 
Date issued after first review: April 2007 (Circular letter 4 of 2007 and amendments). 
Date issued after second review: January 2013 
Area amended: Whole SOP. 
New SOP issue authorised by: Senior Manager: Pharmaceutical Services: Ms. N. Thipa 
 
 
Objectives: 
   To ensure that efficient and effective identification and management of obsolete, expired 
and unusable medication. 
   To  minimise  or  eliminate  losses  due  to  expired,  obsolete  and  unusable  stock  on  the 
shelves. 
   To ensure continuous medicine availability at all institutions by ensuring that all stock kept 
is usable. 
To adhere to the PFMA requirements. 
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Procedure: 
1. On a monthly basis identify expired, excessive, slow moving, unusable and obsolete 
stock within the pharmacy stores, dispensaries, wards and in any area where 
medication is kept. 
 
2. For expired, unusable and contaminated stock (S1 – S4) 
Unusable stock is defined as stock that has been damaged, contaminated, was not 
stored under the recommended storage conditions, declared unsafe for human use or 
has expired in terms of the open vial (multi-dose vial) policy. 
Check expiry date upon receipt of stock and during the monthly 
stock counts. 
Expired stock must be removed from the usable stock immediately and stored 
separately and securely until disposed off. 
    Remove items from the shelves in the presence 
of a witness: 
    Either a pharmacist and pharmacist assistant at a licensed and recorded 
pharmacy or dispensary; 
    Or  a  pharmacist  assistant  and  the  facility  manager  or  member  off  
health  team  as delegated at a dispensary or medicine room; 
    Or by two health care team members in a medicine room, consulting 
room or ward. 
    Medicine destined for destruction must be separated into the following six types 
and clearly labelled: 
Solid dosage forms; 
Creams, ointment and powders; 
Ampoules and liquids 
(contained in glass); 
Aerosols; 
Radioactive medicines; 
Cytostatic and cytotoxic medicines and scheduled substances. 
    All expired stock must be recorded on a VA2 and / or VA27. The following 
information must appear on the Chronological VA2 and / or VA27 (triplicate): 
Alpha code; 
Details of the 
institution; 
Description of 
the item; 
Quantity expired 
or damaged; 
Expiry date; 
Reason for 
expiry or 
damage; Value 
of the expired 
stock; 
Signature of person who removed the expired stock and the witness. 
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Expired stock must be clearly marked as “Expired stock, not 
to be used” 
Update the stock card (modified VA11) with the expired stock removed and record 
the new balance,  with  a  clear  indication  of  the  date  and  reason for  removal  
on  the  stock  card (modified VA11). 
    Expired stock returned to the pharmacy store or medicine room, from the wards, 
clinics or consulting rooms, must be accompanied with the required documentation 
VA2 and / or VA27 and the expired stock returned is not for credit or exchange. 
    A copy of all documentation must be retained at the both the receiving and the 
returning site, in a file labelled “expired, obsolete and unusable stock. 
    The expired items must be handled in accordance to the SOP: Management and 
disposal of expired, obsolete and patient returned medication. 
The Pharmacy (supplier of stock) within the district, hospital or CHC  is required to 
accept expired and unusable stock from the wards, clinics etc, for destruction 
purposes only and reserves the right not to exchange the stock or credit returning 
site. However arrangements can be made within districts for the clinics to dispose 
of their own expired stock, but all procedures of this SOP and the SOP: Disposal 
of expired stock must be adhered to. 
    MSD reserves the right not to accept back expired stock from the institutions, 
unless it was 
expired on receipt and MSD had been notified. 
 
3. For expired, unusable and contaminated stock (SS5 and S6) 
    All relevant procedures for expired stock schedule 1 to schedule 4, applicable to 
the SS5 and 
S6 must be applied 
    Schedule 5 medications should be recorded on a separate VA2 and / or VA 
27 as the procedure for destruction for S5 is different from the schedule one to 
four medicine. 
    Specified Schedule 5 and S6 expired medication should be recorded on a separate 
VA2 and / or VA27 as the procedure for destruction of the S6 medication is 
different from schedule one to four medicine and schedule 5 medicines. 
    The quantity of the expired stock removed from the pharmacy store or cupboard 
must clearly be  subtracted, using a red pen, in the specified S5 or S6 register 
and recorded in the separate expired SS5 and S6 register. This is to ensure 
that on a daily basis the balance in the SS5 and S6 register does not need to 
account for expired stock. This will require the signature of the pharmacist 
responsible for the schedule cupboard and a witness. 
    For expired stock to be returned to the pharmacy within the wards or clinics, 
check that a corresponding entry in made in the ward or clinic register. All stock 
received back in the pharmacy must be recorded in the expired stock register for 
documentation and control purposes. 
    The expired register for the SS5 or S6 medication must contain the following 
information: date,  description of the item, dosage form, expiry date, batch 
number, pharmacy, ward or clinic where the stock expired, quantity and the reason 
for destruction if other than expiry. 
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4. For obsolete (no longer used at the institution) 
On a monthly basis check for obsolete stock. 
Prepare a list of items and forward to the pharmacist. 
The pharmacist will identify other institutions or areas, which may be able to use 
the stock. The pharmacist can request MSD to assist with identifying which 
institutions still use the item not longer used at your facility. 
    The pharmacist will update the overstock item list and circulate to all pharmacy 
managers via email, to inform other institutions of stock available for redistribution. 
    The pharmacist will arrange for the transfer of stock, using the VA5 form, to an 
institution where the stock can be used. 
Update the stock card (modified VA11) accordingly with the transfer out of stock. 
Ensure that the stock card (modified VA11) is clearly marked “Obsolete 
Stock” to prevent reordering of items not used at the institution. 
    Obsolete stock returned to the pharmacy from the wards or clinics must be 
accompanied with the required documentation (VA2) and the obsolete stock 
returned is not for credit or exchange. 
MSD reserves the right not to accept back obsolete stock from the institutions. 
 
 5. For excess, slow moving items or short dated stock 
    Short dated stock which can be used by the facility must be clearly marked and 
put in front of the all the available stock to ensure that it is used first. 
    Short dated stock (within 4 months of expiry) which will not be used must be clearly 
identified and marked for redistributed to high usage areas or institutions. 
    Prepare a list of all stock which has a shelf life shorter than four months, excessive 
stock and slow moving stock and for forward to the pharmacist. 
The pharmacist will identify other institutions that may be able to 
use the stock. 
The pharmacist may request MSD to assist with identifying which institutions still 
use the item not longer used at your facility. 
    The pharmacist will update the overstock item list and circulate to all pharmacy 
managers via email, to inform other institutions of stock available for redistribution. 
The pharmacist will arrange for the transfer of stock to another institution, using the 
VA5 form. Slow-moving and obsolete stock should be identified from the modified 
VA11 by checking the stock holding, the frequency and quantity of demands (stock 
on hand divided by average monthly consumption). This will give the total stock 
holding in months and the pharmacist may then decide on the quantity for 
redistribution.     Overstocking or understocking requires the re-order levels of the 
medicine to be recalculated in line with usage. 
    Excess, slow moving or short dated stock returned to the pharmacy store from 
the wards or clinics must be accompanied with the required documentation 
(VA2). The stock returned is not for credit or exchange as the stock may be 
deemed unfit for further use, at the discretion of the pharmacist 
    MSD reserves the right not to accept back excess, slow moving or short dated 
stock over ordered i.e. by repeated orders due to dues out of an item 
